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The work incorporated in this thesis was conceived and carried out with the
aim of investigating the efficacy and the incidence of side effects when
different regimens for patient-controlled analgesia with morphine sulphate
are used in children. Features of interest were the size of the bolus dose, the
place of a background infusion and its magnitude, an alternative to the
intravenous route of administration and the prevention of postoperative
nausea and vomiting.
In a comparison of patient-controlled analgesia with and without a
background infusion of 20 micrograms kg"1 hour"1 of morphine sulphate there
were no significant differences in the pain scores of the two groups although
there were more side effects in the background group. There was also a
better sleep pattern in this group.
In a comparison of different background infusions, the inclusion of a
background infusion of 4 micrograms kg"1 hour"1 of morphine sulphate did not
increase the incidence of side effects and was associated with less
hypoxaemia and a better sleep pattern than no background infusion,
although it did not improve the efficacy of the technique. When pain was
assessed after movement, the inclusion of a background infusion of 4
micrograms kg"1 hour"1 improved analgesia and was associated with less
hypoxaemia and a better sleep pattern than no background infusion.
When bolus doses of 10 micrograms kg'1 and 20 micrograms kg"1 of
morphine sulphate were compared, 20 micrograms kg"1 produced lower pain
scores and fewer hypoxaemic episodes than 10 micrograms kg"1. There were
no differences between the groups in the incidence of side effects.
In a comparison of intravenous and subcutaneous infusions of morphine
sulphate for the treatment of postoperative pain there were no differences
between the groups in pain scores or the incidence of side effects. The
subcutaneous route appears to be as effective and safe as the intravenous
route for the administration of opioid infusions in children undergoing
elective surgery. In a comparison of the intravenous and subcutaneous
routes of administration for patient-controlled analgesia, the subcutaneous
group had a significantly greater percentage of valid demands for analgesia
than the intravenous group. There were no differences between the pain
scores of the two groups. The intravenous group suffered significantly more
hypoxic episodes than the subcutaneous group. There were no differences
between the groups in the incidence of side effects. Subcutaneous patient-
controlled analgesia appears to be as effective and safe as intravenous
patient-controlled analgesia.
When transdermal hyoscine was compared with placebo for the prevention
of postoperative nausea and vomiting associated with patient-controlled
analgesia, there was a significant reduction in the incidence of postoperative
nausea and vomiting in the treated group compared with the placebo group.
The treated group had a significantly increased incidence of sedation and
dry mouth.
CHAPTER ONE
Background to the Use of Patient-
Controlled Analgesia in Children.
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Postoperative Analgesia in Children
There is convincing evidence that until the mid to late 1980s postoperative
pain in children was substantially under treated compared with the practice
in adults and that most children undergoing surgery suffered considerable
and unnecessary pain while in hospital [Eland and Andersen, 1977; Beyer et
al, 1983; Mather and Mackie, 1983; Schechter, 1989], This situation
occurred during a period when the treatment of postoperative pain in adults
is widely acknowledged to have been grossly inadequate. The reasons for
this state of affairs included a persistent and now discredited belief that
neonates and infants do not feel pain, a general lack of interest in the
subject apart from the efforts of a small number of interested anaesthetists,
fear of the side effects of analgesic drugs and difficulties in the assessment
of pain in children. The situation was compounded by frequent poor
prescribing in terms of dosages and their frequency of administration.
Children often received smaller doses of analgesics than adults on a dose to
weight basis which were administered at longer intervals. When doses were
prescribed on a pro re nata or as required basis they were often
administered in the smallest dose prescribed [Marks and Sacher, 1973].
After equivalent surgical procedures, children were usually given weak
analgesic at an earlier stage in the postoperative course than adults [Beyer
et al, 1983; Mather and Mackie, 1983; Schechter et al, 1986].
Few people now believe that neonates and small infants do not feel pain.
Apart from common sense there is a wealth of scientific evidence to support
the suggestion that neonates and infants can and do experience pain. There
is evidence to suggest that the complete nervous system is active during
foetal life [Valman and Pearson, 1980; Flower, 1985] and the relevant
neuroanatomical, neurophysiological and neurochemical mechanisms are
mature enough in term and premature neonates for them to experience pain.
The density of cutaneous pain receptors is at least the same in neonates as
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in adults [Anand and Hickey, 1987], Neurological tracts in the spinal cord
and brain involved in the central transmission of pain are completely
myelinated from the end of the third trimester [Pounder and Steward, 1992],
Substance P and its receptors are detectable in the foetal dorsal horn from
12-16 weeks of gestation [Charnay et al, 1987; Marti et al, 1987],
Endogenous opioids are present in the plasma [Shaaban et al, 1982] and
cerebrospinal fluid [Orlowski, 1986] of term infants and their concentrations
increase in response to stress. Increases in heart rate, blood pressure and
palmar sweating together with decreases in arterial oxygen saturation are
observed in neonates undergoing painful procedures such as circumcision
[Holve et al, 1983; Williamson and Williamson, 1983] or heel lancing [Owens
and Todt, 1984; Johnson and Strada, 1986] without anaesthesia and these
changes can be prevented by providing analgesia with a local anaesthetic
technique [Holve et al, 1983; Williamson and Williamson, 1983; Maxwell et
al, 1986], The altered behavioural patterns seen after these procedures
[Emde et al, 1971; Anders and Chalemian, 1974; Marskall et al, 1980] are
not seen if local anaesthesia is used to provide analgesia during the
procedure [Dixon et al, 1984], In neonates and infants undergoing surgical
procedures with minimal anaesthesia there is an increased release of
catecholamines, glucagon, Cortisol and growth hormone [Obara et al, 1984;
Anand et al, 1985; Milne et al, 1986; Srinivasan et al, 1986] in response to
these procedures and this is attenuated when potent analgesia is provided
[Anand et al, 1987], Repetitive noxious stimulation in neonates is able to
generate hyperalgesia and persistent increases in the excitability of the
spinal cord and analgesia can prevent this process [Fitzgerald, 1984;
Andrews and Fitzgerald, 1994], There is also evidence to suggest that
untreated pain during the neonatal period may increase the degree of pain
experienced during subsequent invasive medical procedures [Taddio et al,
1995], In summary, the neural pathways and neurotransmitters responsible
for the perception of pain and its modulation are present in the neonate and
the evoked hormonal, metabolic and behavioural responses are similar to
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those seen in older children and adults. It is essential, therefore, to provide
adequate analgesia in all children undergoing surgery.
The Joint Colleges Report on Pain after Surgery from the College of
Anaesthetists and the Royal College of Surgeons in 1990 drew particular
attention to the inadequacy of pain relief in children where the traditional
beliefs and practices which limit the provision of adequate analgesia were
particularly marked. The report made several recommendations aimed at
improving the treatment of postoperative pain. These included improving the
education of medical and nursing staff in pain management, the
establishment of an acute pain service in all major hospitals and the
systematic assessment and recording of pain after surgery.
The Assessment of Pain
The treatment of pain should be directed by valid assessments of pain to
ensure, as far as possible, efficacy without the occurrence of unnecessary
side effects. A pain assessment tool should be able to detect the presence of
pain, to estimate its severity and to determine the effectiveness of analgesic
interventions. In children who old enough to communicate self-report
numerical [Maunuksela et al, 1987] or visual analogue [Berde et al, 1991]
scales as used in adults have been shown to fulfill these requirements and
as subjective reports of pain by the patient are preferable to assessments
made by medical or nursing staff. Graded scales using drawings or
photographs of facial expressions as well as colour scales and body charts
have been described for use in children aged three to six years but are not
widely used. In babies, infants and handicapped children subjective
assessments are not possible and pain assessment is based upon indirect
indicators. Pain assessment tools used in these groups are based on
behavioural, physiological or biochemical indicators. Of the behavioural
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assessments facial expression has been systematically coded for neonates
[Grunau and Craig, 1987] and an objective pain score has been validated in
toddlers undergoing groin surgery [Hanallah et al, 1987], Of the
physiological parameters, changes in heart rate and blood pressure and a
reduction in respiratory sinus arrythmia have been shown to be useful in
term neonates and infants but not in the premature infant [Porter et al, 1988];
a reduction in transcutaneous p02 and an increase in palmar sweating have
also been shown to occur when invasive procedures are performed in
neonates without anaesthesia. Measurements of hormones such as Cortisol,
adrenaline, growth hormone and renin known to increase during stress have
been investigated but are not useful in routine clinical work because of the
practical difficulties of sampling, delay and their limited relevance to pain as
opposed to stress. On a practical day to day level children who are able to
communicate should be asked to score pain using a simple four point self
report scale during a movement such as a deep breath or cough (which is a
more sensitive discriminator than assessments performed at rest) - 0 = no
pain; 1 = mild pain; 2 = moderate pain; 3 = severe pain. Younger children
should be observed by experienced paediatric nurses and scored using a
similar scale - 0 = pain free; 1 = comfortable except on moving; 2 =
uncomfortable at rest; 3 = distressed but can be comforted; 4 = distressed
and unconsolable [Lloyd-Thomas and Howard, 1994], In most cases patients
should be pain free at rest and have minimal discomfort during movement.
During treatment for acute pain assessments should be performed hourly to
ensure efficacy.
Opioids for Postoperative Pain in Children
Options for the treatment of pain in children include physical, psychological
and pharmacological methods. Simple measures such as ensuring warmth,
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swaddling and feeding if appropriate may all be useful. The presence of
parents, reassurance and distraction are also important. Older children
should be given a simple preoperative explanation of what is to happen and
an assurance that any pain experienced will be treated as well as possible.
The main groups of drugs used for analgesia after surgery or trauma are the
same as in adults - opioids, local anaesthetics and non-steroidal anti¬
inflammatory drugs including paracetamol.
Opioids are a versatile and widely used group of analgesic drugs and are
the mainstay of analgesia for most children undergoing intermediate and
major surgery. These drugs interact with three classes of membrane
receptors first described in 1973 [Pert and Snyder, 1973] which are
widespread throughout the central nervous system. Structurally, these
receptors are proteins known as G protein-coupled receptors which
constitute 80% of known membrane receptors. These receptors consist of
seven peptide subunits and span cell membranes. The primary effect of
opioid receptor activation is a reduction in neurotransmission. This is
produced by presynaptic inhibition of neurotransmitter release, although
there may also be postsynaptic inhibition of evoked activity. Receptor
activation causes increased potassium conductance across the nerve cell
membrane (and hence hyperpolarisation), calcium channel inactivation or
both with a reduction in neurotransmitter release [Atcheson and Lambert,
1994], There are also peripheral actions of opioids. Opioid receptors exist on
the peripheral ends of primary afferent neurones and their activation may
directly decrease neurotransmission or inhibit the release of excitatory
neurotransmitters such as substance P. There is clinical evidence in support
of a clinical role for opioids as peripheral analgesics [Stein et al, 1993],
There are three subtypes of opioid receptor known as mu, kappa and delta
receptors. Mu receptors are associated with analgesia, respiratory
depression, euphoria, sedation and physical dependence [Vaught et
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al, 1982], Kappa receptors are located mainly in the spinal cord and are
responsible for analgesia produced at cord level and dysphoria [Wood,
1982; Snyder, 1984], Delta receptors mediate respiratory depression caused
by exogenous opioids although their physiological role is unclear [Pleuvry,
1991], The endogenous ligands for these receptors are three groups of
structurally related opioid peptides which bind to the receptors. These are
beta-endorphin, dynorphin related peptides and the enkephalins.
The most commonly used opioid is morphine sulphate and there is more
clinical experience with this in children than with any of the other opioids. As
well as producing analgesia the various opioids produce a similar spectrum
of side effects. At equipotent analgesic doses all the pure agonist opioids
produce similar degrees of respiratory depression, sedation, euphoria,
nausea, and constipation [Jaffe and Martin, 1985], They have the
disadvantage of a relatively narrow therapeutic range and marked variability
in response between patients because of pharmacokinetic and
pharmacodynamic variability. This is particularly marked in children aged
less than three months where drug elimination is very variable with
diminished clearances and prolonged half-lives [Koren et al, 1985; Koehntop
et al, 1986; Greeley et al, 1987; Lynn and Slattery, 1987; Singleton et al
1987], In neonates and young infants the volume of distribution of opioids is
greater than in older children [Greeley et al, 1987], the blood-brain barrier is
more permeable [Kupferberg and Way, 1963; Sanner and Woods, 1965],
there are reduced plasma protein concentrations (especially alpha-1-acid
glycoprotein) with consequent high levels of free drug [Morselli et al, 1980]
and there may be a preponderance of Mu 2 receptors which mediate
respiratory depression caused by opioids [Pasternak et al, 1980; Leslie et al,
1982]. Clinically, there is undoubtedly an increased sensitivity to the
depressant effects of opioids in the first three months of life [Way et al, 1965;
Koren et al, 1985; McNicol, 1994], After this the enzymatic pathways
responsible for opioid metabolism mature [Koren et al 1985; Olkkola et
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al, 1988] and the pharmacokinetics of opioids become more like those of
adults [Dahlstrom, 1979; Hertzka, 1987], They may be administered more
liberally with safety in these older infants. With sensible dosage regimens
and appropriate monitoring, the use of opioids in healthy children older than
three months provides excellent analgesia with a wide margin of safety
although problems may still occur if they are used in an inappropriate
manner [Gourlay and Boas, 1992; Wolf, Lawson and Fisher, 1995],
There are, of course, older children who can be expected to be particularly
susceptible to the depressant effects of opioids because of specific diseases
or sensitivities e.g. those with severe respiratory disease, upper airway
obstruction and renal or hepatic impairment. The concurrent administration
of other centrally acting sedative drugs with opioids puts the patient at
considerable risk of over sedation and respiratory depression.
The analgesic effect of opioids depends on the brain concentration of active
compounds which is related to plasma levels. Intermittent intramuscular
administration is unlikely to produce steady plasma levels [Austen et al,
1980; Grabinski et al, 1983] and may result in widely fluctuating plasma
levels of opioids. This tends to produce periods of analgesia and excessive
sedation alternating with periods of inadequate pain relief [Angell, 1982;
Berde, 1989], Intermittent intramuscular injections may cause such distress
to children that they are not requested [Eland and Andersen, 1977], These
factors, combined with the need for two qualified nurses to administer a dose
of analgesic, may lead to long periods of inadequate pain relief when
intermittent intramuscular injections are used to provide analgesia in
children.
The intermittent administration of intravenous bolus doses of an opioid on an
as required basis has the potential to provide extremely good analgesia with
a high degree of safety. If pain is assessed conscientiously and analgesia
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given when required then excellent analgesia can be achieved which takes
account of the great variability in patient requirements which arises because
of pharmacokinetic and pharmacodynamic factors. This method of
administration has the further advantage of requiring assessment of the
patient before a dose of opioid is given and avoiding obligatory opioid
administration irrespective of the condition of the patient. Because it is a
relatively labour intensive method of administering opioids, intermittent bolus
dose administration is rarely used. Despite this it is a very useful and safe
method of giving analgesia to children especially neonates and premature
babies, for the early treatment of pain following trauma in Accident and
Emergency Departments and in the .immediate postoperative period in the
recovery area.
Opioids by Infusion in Children
The technique of continuous intravenous infusion of an opioid solution has
become popular because of its efficacy, simplicity and wide range of
indications. Continuous infusion will maintain a steady blood concentration
of opioids once equilibration is reached and avoids the need for repeated
injections. A loading dose is required to avoid the prolonged period of four to
five half lives required to reach a steady state. The efficacy of this technique
in children has been shown in several series. Beasley and Tibbals used
infusions of 10-40 micrograms kg"1 hour'1 in 121 children undergoing major
surgery with no significant respiratory depression (although this was
assessed by four hourly respiratory rates). In 44 children from 14 months to
seventeen years infusions from 10-50 micrograms kg'1 hour"1 were effective
with mild hypercarbia seen in three children receiving 40-50 micrograms kg"1
hour"1 [Lynn et al, 1984], Dilworth and McKellar reported a series of 144
patients from 6 months to 15 years receiving papaveretum 50-70 micrograms
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kg"1 hour'1 and noted bradypnoea in 5% of subjects. The technique of an
infusion following a bolus dose has been demonstrated to provide better
analgesia than intramuscular injections [Bray, 1983; Hendrickson et al,
1990], An intravenous infusion of 10-40 micrograms kg"1 hour"1 of morphine
sulphate following a bolus of 150 micrograms kg"1 provided equivalent
analgesia to an epidural infusion of 0.1-0.4 ml hour"1 of 0.25% bupivacaine in
infants undergoing abdominal surgery [Wolf and Hughes, 1992]. In this study
patients receiving a morphine infusion had a lower respiratory rate than
those receiving an epidural infusion but this was not clinically significant and
was not associated with hypoxia while breathing air. Continuous intravenous
infusion of papaveretum up to 37.5 micrograms kg"1 hour"1 in infants between
four weeks and six months of age provided very good analgesia with only
one incident of clinically significant hypoventilation detected by continuous
pulse oximetry while breathing air [Jones and Stokes, 1991],
The technique of a continuous intravenous opioid infusion is suitable for
children younger than 7-8 years and older children who are unable to use
patient-controlled analgesia. Dosages in the range 10-40 micrograms kg"1
hour"1 of morphine are adequate in most patients and infusions are usually
started in the middle of this range for children over six months and at 5-10
micrograms kg"1 hour"1 for those younger.
The effective use of intravenous infusions requires close nursing supervision
to ensure that the infusion rate is adequate and titrated against needs which
will change with time and activity such as mobilisation and physiotherapy.
Because of the obligatory opioid administration without patient assessment
and feedback which is inherent in an infusion technique there is a necessity
to monitor patients closely to assess efficacy and prevent the occurrence of
side effects particularly respiratory depression and over sedation. There is
also a danger of excessive drug administration because of incorrect drug
dilutions, machine malfunction or incorrect programming of the pump. If
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infusions are administered through the same intravenous cannula as
intravenous fluids there is a danger that opioid will reflux into the intravenous
fluids and a subsequent uncontrolled bolus may be delivered. To prevent
this infusions should be administered via a dedicated cannula or an anti¬
reflux valve.
An alternative method of delivering a continuous infusion of an opioid is to
use the subcutaneous route of administration. This technique has been
shown to be effective in adults [Hindsholm et al, 1993] and children
[McNicol, 1993], It is subject to the same potential dangers as the
intravenous route.
Patient-Controlled Analgesia
Patient-controlled analgesia is an analgesic technique whereby the patient is
able to self-administer bolus doses of opioid with a degree of flexibility within
a prescription which sets the bolus dose administered, the obligatory delay
between boluses (lockout interval), the presence or absence of a
background infusion and, usually, a maximum dosage over a period of four
hours. Most machines comprise an infusion pump with software allowing the
use of a trigger device to deliver bolus doses with or without a variable
background infusion [Abbott Laborities Ltd; Graseby Medical Ltd; Bard
International Ltd; IVAC; Kabi Pharmacia], Mechanical patient-controlled
analgesia machines such as the Baxter infusor [Baxter Healthcare Ltd] and
the Vygon Freedom PCI Set [Vygon (U.K.) Ltd] make use of a depot
chamber which is filled by a pressurised infusor or a vacuum and controlled
by a spring loaded clamp. The time taken for the depot chamber to fill
comprises the lockout interval [Mackey et al, 1993], These devices have
been used successfully in children [Irwin, Gillespie and Morton, 1992], There
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are also compact battery powered units available for mobile patients which
have a role in terminal care and chronic pain [Chrubasik, 1984; Wermeling
et al, 1987],
The Development of Patient-Controlled Analgesia
The principle of patient-controlled analgesia developed in the 1960s as a
result of attempts to measure or quantify postoperative pain in psychological
studies [Sechzer, 1968], Patients were instructed to press a button and
inform a nurse when they felt pain and required analgesia. This was
delivered by the nurse using a spring loaded clamp on an infusion line and
the opioid consumption was noted. A benefit of this method of assessing
pain was noted to be excellent analgesia. Apart from the efforts of a few
enthusiasts, there was little subsequent interest in this technique for nearly
twenty years because of a lack of interest in the treatment of postoperative
pain, the introduction of epidural infusions for much major surgery and the
lack of suitable reliable equipment. A hand held spring loaded clamp
controlling a pethidine infusion was used for obstetric analgesia [Scott,
1970], Sechzer went on to employ a fixed rate roller pump with two electro¬
mechanical timers [Sechzer, 1971], This device demonstrated the important
features of modern patient-controlled analgesia machines - the patient made
a demand for analgesia by pressing a button, there was a fixed bolus dose
given in response to this demand (controlled by the first timer) and there was
a refractory period during which no further doses would be administered
(controlled by the second timer). Devices based on a syringe driver
appeared [Keeri-Szanto, 1971; Evans et al, 1976], A device controlled by a
microprocessor was developed and was commercially available for a period
as the On-demand Analgesic Computer (ODAC) [Hull and Sibbald, 1981;
Hull, 1985], With the development of commercially available pumps capable
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of delivering accurately the small boluses required with lockout intervals and
simultaneous interest in improving the standard of postoperative analgesia,
patient-controlled analgesia rapidly became a common analgesic technique.
When used appropriately patient-controlled analgesia has the potential to
provide good analgesia which is flexible enough to respond to the changing
needs of patients with time and to take account of events such as
physiotherapy and mobilisation with the prophylactic administration of a
bolus. The technique should also take account of the great variability
between patients in terms of the perception of pain and their
pharmacokinetic and pharmacodynamic variability. Patients who perceive
pain requiring treatment are able to self-administer within the limits of the
prescription without reference to medical or nursing staff and their
perception of the patient's distress. Doctors and nurses have been found to
consistently underestimate the degree of pain compared with simultaneous
patient assessments in adults [Klopfenstein et al, 1995] and children
[Weldon, 1991], Patients who metabolise opioids rapidly or who have a
degree of pharmacodynamic resistance will be able to self administer more
frequently than others who require less opioid while both groups receive
adequate analgesia and remain satisfied.
The efficacy of patient-controlled analgesia has been well documented in
adult practice and it has been shown to be superior to intermittent
intramuscular injections [Keeri-Szanto, 1972; White et al, 1979; Slattery et
al, 1983; Atwell et al, 1984; Wasylak et al, 1990; Boulanger et al, 1993] and
to provide comparable analgesia to an epidural infusion of local anaesthetic
[White et al, 1979] or to epidural opioids [Rosenberg, Heino and Scheinin
1984; Stoddart et al, 1993], There is evidence that the optimal use of patient-
controlled analgesia after major surgery is associated with less
postoperative morbidity and earlier discharge than the use of intermittent
intramuscular analgesia [Wasylak et al, 1990] although this may also be the
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case with other techniques which optimise postoperative analgesia after
major surgery.
Since patient-controlled analgesia requires not only patient cooperation but
active participation and a willingness to take responsibilty for an aspect of
hospital care, it may be expected that the influence of psychological factors
on this method of analgesia will be profound. In patients undergoing the
same operative procedure there is great variability in the definition,
perception and tolerance of pain after the procedure. There is also great
variability in the distress caused to individual patients by pain and in their
willingness to communicate this to medical and nursing staff. It is known that
the analgesic effects of a given dose of analgesic can be greater when self-
administered as opposed to nurse-administered [Keeri-Szanto, 1979] and
that non-pharmacological factors have a profound influence on the
effectiveness of a given analgesic intervention [Keeri-Szanto, 1979], The
effect of anxiety on pain and its perception is profound and in many patients
the ability to control their analgesia reduces anxiety and may be expected to
decrease the intensity of the perceived pain [Bowers, 1968; Wilson and
Bennet, 1984], Other personality traits which are relevant include the degree
of introversion or extroversion and neuroticism. Ethnic background, previous
experience and beliefs about pain and surgery may all affect the perception
of pain. It has been suggested that patients who attempt to deal with
situations and threats by seeking information and mastery of situations (a
vigilant coping strategy) will benefit from patient-controlled analgesia by
gaining a measure of self-control over analgesic administration and the
degree of discomfort suffered. It allows patients to titrate themselves to a
situation where there is an acceptable balance between the degree of
discomfort or pain experienced and opioid induced side effects particularly
nausea and vomiting. Conversely, some patients are unwilling to use
patient-controlled analgesia appropriately and perceive this method of
analgesia as threatening and prefer infusion or nurse-administered
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analgesia. Those who adopt avoidance type coping strategies may well feel
threatened by patient-controlled analgesia [Wilson and Bennet, 1984], It has
been demonstrated that patients' coping styles for stress correlate well with
the effectiveness of patient-controlled analgesia [Wilson and Bennet, 1984],
There is nothing published on the psychological aspects of patient-controlled
analgesia in children.
Patient-Controlled Analgesia in Children
In paediatric practice, patient-controlled analgesia was first described in
1987 [Brown and Broadman, 1987] in a series of adolescents aged 11-
19 years undergoing orthopaedic, abdominal and thoracic surgery. This and
several other descriptive series of patients [Dodd et al, 1988; Means et al,
1988; Rogers et al, 1988; Broadman et al, 1989, Gaukroger et al, 1989;
Broadman et al, 1990; Lawrie et al, 1990; Mowbray and Gaukroger, 1990]
demonstrated the efficacy of patient-controlled analgesia in suitable children
and led to its wider use. Demonstration of the superiority of patient-
controlled analgesia to intermittent intramuscular injections soon followed.
Berde et al randomised children aged 7-19 years undergoing orthopaedic
surgery to receive intermittent intramuscular injections of morphine
100-180 micrograms kg"1 three hourly as required for pain or patient-
controlled analgesia with a bolus dose of 25 micrograms kg'1 and a lockout
interval of 10 minutes with a four hourly maximum of 240 micrograms kg'1.
Pain was assessed by patient and nurse visual analogue scales and was
significantly less in the group receiving patient-controlled analgesia than in
the group with intramuscular injections [Berde et al, 1991]. A paediatric study
comparing patient-controlled analgesia using morphine with a continuous
infusion of morphine has demonstrated better pain relief with patient-
controlled analgesia in appropriate patients [Bray et al, 1995],
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Patient selection for patient-controlled analgesia depends on a number of
features including the age of the child, their developmental stage and
intelligence. The only absolute requirements are the ability to understand the
concepts of demand analgesia and a lockout interval and to be physically
able to operate the trigger of the patient-controlled analgesia machine.
Features which may affect the suitability of the child for patient-controlled
analgesia include the attitude of the parents, previous experience,
unwillingness to be involved in their own care and the severity of illness.
With adequate explanation and postoperative supervision many children
aged 8 years and over can use patient-controlled analgesia appropriately as
can some younger children down to five years of age although problems are
more common in younger children. Appropriate and sensible use of a
patient-controlled analgesia machine requires preoperative tuition of the
child and parent(s) and postoperative reinforcement of this tuition
particularly the concept of a lockout interval. Children should never be
guaranteed complete analgesia from patient-controlled analgesia after
surgery.
Most patient-controlled analgesia pumps designed for adult use are suitable
for paediatric use. There does not seem to be a need for dedicated
paediatric models. Most units prefer to vary the dilution of the opioid solution
and maintain a constant volume in the syringe to permit dose administration
on a mg kg"1 basis in a constant volume. Children old enough to use patient-
controlled analgesia are usually able to press the trigger of most patient-
controlled analgesia machines and modified triggers are available if
necessary. Single use patient-controlled analgesia devices are available but
they are relatively inflexible and expensive. Most units prefer to use
electronic machines where the cost per patient is less and there is the facility
to vary the settings from a standard recipe if required. Models should be
lockable to prevent misappropriation of the syringe and prevent
unauthorised changes in the settings. The facility to store data on usage of
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the machine, opioid consumption and the numbers of valid demands which
can be retrieved or down loaded is useful for research and audit purposes.
Safety Aspects of Patient-Controlled Analgesia
There are a number of potential problems associated with the use of patient-
controlled analgesia in children. Inappropriate patient selection is likely to
result in failure of the technique to provide analgesia and may lead to
inappropriate use and excessive opioid consumption with sedation and
respiratory depression. Even with careful patient selection and conscientious
preoperative tuition which is reinforced after surgery, there will be a number
of children who do not use the pump appropriately and refuse to press the
trigger, resulting in unrelieved pain, or who administer excessive and
unnecessary opioid. If the situation does not improve after an explanation of
more appropriate use, it is usually appropriate to change to a straightforward
infusion technique. There is a perception that patient-controlled analgesia is
safer than infusions of opioids because excess administration will produce
somnolence which prevents subsequent self administration of opioid. This is
true to a degree but the safety is relative and not absolute since various
factors may bypass this inherent safety of the technique.
The potential problems which may occur can be divided into those due to
errors by medical and nursing staff, misuse by the patient or others and
faults in the equipment.
Errors may be made in the dilution of opioid used for the pump (this should
always be checked by a second person), in programming the device [White,
1987], in priming the pump and in the omission or misplacement of an anti¬
reflux valve. When changing syringes or cartridges there is the potential for
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inadvertent bolus dose administration if the tubing to the patient is not
clamped or closed during the change [White, 1987],
If people other than the patient press the trigger then the technique loses its
inherent safety [Lam, 1993], There may be intentional meddling with the
pump by the patient or others [Stevens et al, 1991; Youngs, 1993], Because
of inadequate preoperative education or forgetfulness, patients may self-
administer excessive doses of opioid [Johnson and Daugherty, 1992], The
mistaken use of a patient-controlled analgesia trigger as a nurse call device
has been described resulting in excessive opioid administration [Farmer and
Harper, 1992; Morton, 1993].
Patient-controlled analgesia pumps may malfunction and deliver more or
less opioid than intended because of a software malfunction or external
electrical power surges despite 'self-checking' facilities built into the software
[Nottcut et al, 1992], There is a risk of reflux if a dedicated cannula is not
used. A combination of a break in the continuity of the opioid delivery system
and positioning of the opioid containing syringe above the patient may cause
a gravity-fed syphon effect where all the available opioid is delivered to the
patient as a bolus [Thomas and Owen, 1988], Disengagement of the syringe
from the driving mechanism may have the same result [Grover and Heath,
1992], Manufacturing faults in single use disposable devices have been
reported which would produce a rapid large delivery of opioid to the patient
[Costigan, 1994], Failure to remove the priming plate supplied with the
Baxter single use device or the exertion of continual pressure on the patient
control button converts the device to a constant infusion pump [Arnstein,
1994]. The Vygon single use device may deliver as much as 50% more
opioid than intended if demands for analgesia are made frequently during
the lockout interval. This occurs because filling of the reservoir chamber is
non-linear and is 90% complete within three minutes while complete filling
takes five minutes which is the nominal lockout time of the device. Frequent
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demands for analgesia during the lockout interval will lead to the delivery of
more opioid than prescribed [Smith, 1995], In the presence of hypovolaemia,
normal bolus doses of opioid may be excessive and may cause significant
respiratory depression [Owen et al, 1988],
As with all opioid based techniques, the side effects of opioids are a
potential problem. The most dangerous of these is respiratory depression
but over-sedation, nausea and vomiting, urinary retention and pruritis are all
possible. In the absence of a dedicated Acute Pain Service, the burden of
preoperative preparation and postoperative supervision may be
considerable. Despite these theoretical and actual problems with the use of
patient-controlled analgesia in children, the technique is very safe in clinical
practice when used and monitored appropriately. In the largest reported
series of over 1500 children receiving patient-controlled analgesia two
children were given naloxone for somnolence and a low respiratory rate of
6-8 breaths minute'1. Both of these children had received concurrent
sedative medications during the use of patient-controlled analgesia [Wilder
et al, 1992],
A Monitoring Protocol for the Use of Opioids in
Children
The potential problems which can occur with opioid administration by any
route necessitate the implementation of some form of monitoring protocol
which will detect potential problems at an early stage and provide warnings
which can be acted upon to prevent the situation deteriorating. A simple and
effective protocol has been described for this purpose [Morton, 1993]. In the
context of opioid administration by infusion or patient-controlled analgesia,
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the features of interest are a measure of respiratory depression or
hypoventilation, an assessment of the level of sedation or consciousness,
opioid consumption and machine performance. The intermittent recording of
respiratory rate has been shown to be a late and insensitive monitor of
hypoventilation [Catley et al, 1985; Wheatley et al, 1990; Kluger et al, 1992]
and this cannot be relied upon to give an early warning of this problem. The
use of pulse oximetry while breathing air is a more sensitive monitor of
hypoventilation [Hutton and Clutton-Brock, 1993] and in the absence of other
causes of hypoxia such as impaired gas exchange, mild hypoxia (arterial
oxygen saturation {Sp02} < 94%) indicates mild hypoventilation. This may be
a consequence of excess opioid administration or of pain limiting respiratory
movements and discrimination between the two requires assessment of
opioid consumption, pain scores and level of sedation. A subject in pain will
be alert and unwilling to take a deep breath or cough while a subject who
has received excess opioid will be sedated.
Somnolence caused by opioids tends to occur at an early stage and is a
valuable early warning of excessive opioid administration. When used in
conjunction with pulse oximetry this helps to discriminate between the
possible causes of hypoxia. In patients breathing supplementary oxygen
arterial oxygen saturation (Sp02) is not a useful monitor of hypoventilation
and the level of sedation becomes the most important method of detecting
excessive opioid administration at an early stage. To be used properly the
measure of sedation should be as objective as possible to avoid bias
between observers and with time. This should ensure that different
observers looking at the same patient will give the same sedation score and
that important changes in the status of the patient are reflected by changes
in the score. The components of the Glasgow Coma Scale which relate to
eye opening fulfil these requirements. There is a potential problem with
discrimination between sleep and over sedation with concern being
expressed that unless patients are woken regularly it is impossible to be
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sure that they are not over sedated. With practice and experience paediatric
nurses can usually discriminate between a child who is naturally asleep and
one who is beginning to receive excessive opioid. A child who is asleep has
a good colour and peripheral perfusion and breathes in an easy
unobstructed manner with an Sp02 of over 95% while breathing air. A child
becoming over sedated may breath with the mouth hanging open and be
partially obstructed. An Sp02 of less than 94% is uniform. Sensible and
experienced paediatric nurses are usually able to discriminate between
these situations and as long as they are prepared to stimulate a child if there
is the slightest doubt this system has proved to be very satisfactory in
clinical practice at providing early warning of excessive opioid
administration.
The incorporation of a score for postoperative nausea and vomiting tends to
make doctors and nurses more aware of this distressing symptom and this
may encourage early treatment, if required, as well as assessment of the
efficacy of the antiemetic treatment which is given.
Regular checks on the performance of the infusion pump or patient-
controlled analgesia machine to ensure that appropriate doses of opioid are
being administered and that the machine has not failed or over delivered are
necessary. Although problems of this kind are rare, they are potentially
disasterous. When patient-controlled analgesia is used, if there is a
significant difference between the numbers of demands for analgesia which
are made and the number which are successful this may suggest that the
machine is being used inappropriately and that a further explanation of
correct use is required or that the settings are inadequate for the patient.
21
Further Aspects of Patient-Controlled Analgesia
A further aspect of patient-controlled analgesia which may be useful on
occasion is its ability to act as a pain measuring device. This is a return to
the original concept which led to patient-controlled analgesia and allows
studies of various analgesic techniques in an ethical manner with patient-
controlled analgesia being used by patients to make up for any deficiency in
the analgesic regimen(s) under investigation (rescue analgesia). The opioid
consumption by patient-controlled analgesia is then used as one indicator of
the degree and duration of pain experienced by the subject and the efficacy
or otherwise of the interventions under investigation.
A variation on patient-controlled analgesia which has been used
successfully in children is nurse-controlled analgesia [Lloyd-Thomas and
Howard, 1994], With this technique a modest infusion of morphine sulphate
(10-20 micrograms kg'1 hour"1) is supplemented by additional boluses
(10-20 micrograms kg"1) given at the discretion of the nurse caring for the
child with a lockout interval of 15-30 minutes and a four hourly maximum
dose. This offers the advantages of avoiding a generous fixed infusion rate
which may be excessive in some subjects while offering a basal level of
analgesia which can be supplemented as required and titrated to the needs
of the child. It also has the advantage of requiring an obligatory assessment
of the patient by the nurse before any opioid boluses are administered.
When used appropriately nurse-controlled analgesia appears to be a very
effective and safe form of postoperative analgesia which combines some of
the better features of both fixed infusions and patient-controlled analgesia in
children unable to use patient-controlled analgesia properly.
The use of a patient-controlled analgesia machine by parents to administer
analgesia to children has been described [Broadman et al, 1990], This was a
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small series and some parents found the process very stressful. The
technique has not become popular and most workers consider that the
emotional involvment of parents and their lack of training make them
unsuitable to reliably make impartial decisions about the administration of
potent analgesics to their child.
Patient-controlled analgesia has been used for chronic and terminal pain in
adults [Citron, 1986; Kerr, 1988] and children [Mowbray and Gaukroger,
1990] and for terminal care in ambulatory children [Doyle and Morton, 1994],
Proposed Project
In 1992, despite the growing body of experience with patient-controlled
analgesia in children, most of the reported experience consisted of series of
patients which demonstrated the efficacy of the technique or its superiority to
intermittent intramuscular injections. The technique was becoming widely
used but there was no published work investigating patient-controlled
analgesia to compare the different regimens in use in a scientific manner
and there was no evidence to support the superiority of any particular
patient-controlled analgesia regimen in children. The work incorporated in
this thesis was conceived and carried out with the aim of investigating this
area in a series of randomised, controlled studies to determine the efficacy
and the incidence of side effects of different regimens. Features of interest
were the size of the bolus dose, the place of a background infusion and its
magnitude, the place of the subcutaneous route as an alternative to the
intravenous route of administration and the treatment of postoperative
nausea and vomiting.
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In order to allow valid comparisons between groups a standard surgical
procedure was used for most of the studies. This was the operation of
appendicectomy which provides a good model for the study of postoperative
analgesic regimens in children. It provides a standard incision and surgical
procedure with a degree of peritoneal irritation which is magnified by the
movements of respiration and mobilisation. This ensures that postoperative
morphine requirements when self-administered with a patient-controlled
analgesia machine are of the order of 20-30 micrograms kg"1 hour"1 which is
the same as that seen in many children after more major abdominal and
orthopaedic procedures [Brown and Broadman, 1987; Rogers et al, 1988;








Forty children aged 6-14 years undergoing appendicectomy were randomly
allocated to receive one of two patient-controlled analgesia regimens with
intravenous morphine sulphate. Group BO received a bolus dose of
20 micrograms kg"1 with a lockout interval of five minutes and no background
infusion and Group B20 received a bolus dose of 20 micrograms kg"1 with a
lockout interval of five minutes and a continuous background infusion of
20 micrograms kg 1 hour"1. Patients breathed air and oxygen saturation was
monitored by continuous pulse oximetry. Scores for pain, nausea and
sedation were recorded hourly. Group B20 received significantly more
morphine than Group BO. Both groups self-administered similar amounts of
morphine using the patient-controlled analgesia machine. There were no
significant differences between the pain scores of the two groups. Group
B20 suffered more nausea (p < 0.01), more over sedation (p < 0.05) and
more hypoxic episodes (p < 0.001) than Group B0. Group B20 had a better
sleep pattern than Group B0.
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Introduction
Patient-controlled analgesia has been used in children since 1987 [Brown
and Broadman, 1987], initially in adolescents and later in selected children
as young as five years. The drug used most commonly has been morphine
sulphate with a bolus dose of 10-25 micrograms kg"1 and a lockout interval of
5-15 minutes. A continuous background infusion has been used in some
studies.
The addition of a background infusion to patient-controlled analgesia may
improve the quality of analgesia provided by maintaining plasma
concentrations of opioid and in particular by limiting the reduction in plasma
concentrations which occurs during sleep [Kay, 1981], However, a fixed
infusion may reduce the inherent safety of patient-controlled analgesia by
continuing to deliver opioid to a patient who has adequate analgesia and is
at risk of overdose if further opioid is administered [Owen, Mathers and
Rowley, 1988], The use of a background infusion may also result in larger
amounts of opioid being administered and an increase in the incidence of
opioid-induced side effects [McKenzie, 1988].
This study was carried out to assess the effect on postoperative analgesia,
sedation, ventilatory frequency, arterial oxygen saturation (Sp02), nausea
and vomiting and sleeping pattern of adding a background infusion to a
patient-controlled analgesia regimen with morphine sulphate in children.
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Patients and Methods
The study was approved by the hospital Ethics Committee and written
informed parental consent was obtained for each subject. Forty children
aged 6-14 years undergoing appendicectomy were studied. Patients were
visited preoperatively when the principles of using patient-controlled
analgesia were explained to the child and parents and the patients were
taught how to use the trigger of the patient-controlled analgesia machine.
Patients were not recruited if they had received preoperative analgesia.
All patients received a standard general anaesthetic which consisted of a
rapid sequence induction with thiopentone 5-7 mg kg"1 and suxamethonium
1 mg kg'1. The trachea was intubated and the lungs ventilated with isoflurane
0.5-2% with 70% nitrous oxide in oxygen. Neuromuscular blockade was
maintained with vecuronium 0.1 mg kg'1. Morphine sulphate 0.1 mg kg"1 was
given during the procedure. At the end of surgery, residual neuromuscular
blockade was antagonised with neostigmine and glycopyrrolate in
appropriate doses. In the recovery area, patients were made pain free with
increments of 50 micrograms kg"1 of morphine sulphate as required.
Before patients left the recovery area the patient-controlled analgesia
machine (Graseby PCAS or Graseby 3300) was connected. The solution
used consisted of morphine sulphate 1 mg kg'1 diluted in 50 ml of normal
saline to give a concentration of 20 micrograms kg"1 ml"1. The patient-
controlled analgesia machine was attached to the side arm of a Cardiff one
way valve connected to the intravenous cannula. The settings used were a
bolus dose of 1 ml (20 micrograms kg"1) with a lockout interval of five
minutes. Patients were randomly allocated (by means of a computer
generated list) to receive either no background infusion or a background
infusion of 1 ml hour"1 (20 micrograms kg"1 hour'1) of morphine sulphate.
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After operation patients breathed air and a monitoring regimen described
previously [Morton, 1993] was used. The arterial oxygen saturation was
monitored continuously and there were hourly recordings of respiratory rate,
a pain score, a sedation score, a nausea score, the number of demands
made and the volume of solution infused. Oximeter readings were
considered valid if artefact was excluded and the reading was consistent
over several minutes with a good pulse signal displayed on the oximeter
screen. A hypoxic episode was defined as an Sp02 of less than 94%.
Pain was recorded using a four-point self reporting score which has been
validated previously [Maunuksela et al, 1987]: 0 = no pain, 1 = not really
sore, 2 = quite sore, 3 = very sore. Subjects who were asleep were allocated
a score of 0.
Sedation was scored using a four point scale: 0 = eyes open spontaneously,
1 = eyes open to speech (also used for subjects who were considered to be
asleep), 2 = eyes open when shaken, 3 = unrouseable. Over sedation was
defined as a score of 2 or 3.
Nausea and vomiting was scored on a four point scale: 0 = none, 1 = nausea
only, 2 = vomited once in the past hour, 3 = vomited more than once in the
last hour.
Patient-controlled analgesia was discontinued when there was a consistent
decline in use and patients were able to take oral analgesics.
Statistical analysis was with Student's t test for parametric data (ages and
weights), the Mann-Whitney U test for non-parametric data (opioid
consumption, duration of P.C.A. and pain scores) and the Chi squared test
for categorical data (comparisons of events between groups).
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Results
The two groups were similar with regard to demographic data and surgical
details (Table 2.1).
Table 2.1. Demographic data (mean (SD)) and times of operation in Groups
BO and B20.
Group B0 Group B20
Sex (M:F) 11:9 12:8
Age/years 9.6 (1.7) 10.2 (1.4)








The total morphine consumption in Group B20 was significantly greater
(p<0.01) than in Group BO. There was no significant difference in the
amounts of morphine self-administered by the two groups (Table 2.2).
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Table 2.2. Details of morphine consumption (Median (Range)) in Groups BO
and B20.
Group BO Group B20
















micrograms kg"1 720 (200-1020)
** Significant difference between groups (p < 0.01).
For each patient the hourly pain scores during each four hourly interval after
operation were summed and a median total pain score in each Group for
each four hourly interval calculated. Comparisons of these scores showed
no significant differences between the groups during any period (Figure 2.1).
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There were significantly more hypoxic episodes (Sp02 < 94%) in Group B20
(143 episodes) than in Group BO (94 episodes) (p < 0.001). The lowest
values for Sp02 recorded ranged from 83-95% (mean 91%) in Group B20
and from 88-94% (mean 92%) in Group B0.
A respiratory rate of less than 10 breaths minute"1 was noticed on four
occasions in the same patient in Group B20. The Sp02 values on these
occasions were 96%, 93%, 97% and 90% respectively. The slowest
respiratory rated in the two groups ranged from 7-18 breaths minute"1 (mean
16 breaths minute"1) in Group B20 and from 12-20 breaths minute"1 (mean
17 breaths minute"1) in Group B0.
The occurrence of sedation scores of 2 or 3 was compared. There were no
recordings of 3 in either group, but there was a significantly greater number
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of occasions when a score of 2 occurred in Group B20 (13 episodes) than in
Group BO (4 episodes) (p < 0.05).
There was a significantly higher incidence of vomiting in Group B20 (37
episodes) than in Group BO (15 episodes) (p < 0.01). Antiemetics were given
to one patient in Group B20.
The amount of time that patients in the two groups spent asleep was
compared separately for the periods from 22:00-06:00 (night) and from
06:00-22:00 (day). Patients in Group B20 spent significantly more time
asleep at night than those in Group B0 (p < 0.001). There was no difference
between the groups in the time spent asleep during the day (Table 2.3).
Similar numbers of patients in both groups underwent surgery during the day
and at night. The effect of timing of operation on subsequent postoperative
sleep pattern can, therefore, be expected to be similar in both groups.
Table 2.3. Comparison of the amount of time in hours spent asleep at night
and during the day in Groups B0 and B20.















*** Significant difference (p < 0.001) between Groups.
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The analgesia provided in both groups was generally very good with only
119 scores of 2 (= quite sore) and 3 (= very sore) from a total of 1521
observation (59 of 759 observations in Group BO and 60 of 762 observations
in Group B20).
One child in Group B20 had the infusion discontinued because of a
persistently low Sp02 when asleep, although the respiratory rate was always
greater than 14 breaths minute"1.
Discussion
This study found that the use of a background infusion of morphine sulphate
of 20 micrograms kg'1 hour'1 in a patient-controlled analgesia regimen for
children undergoing lower abdominal surgery produced a significant
increase in morphine consumption without improving pain relief and a
significant increase in the incidence of side effects (respiratory depression,
over sedation and nausea and vomiting). Patients in Group B20 did,
however, spend more time asleep at night than those in Group BO.
The use of a concurrent background infusion with patient-controlled
analgesia in adults is an area of debate in the literature. A background
infusion has been shown to improve pain relief in two studies [Sinatra et al,
1989; McKenzie, Rudy and Tantisira, 1990], In one of these [McKenzie,
Rudy and Tantisira, 1990], the use of a background infusion after
hysterectomy not only improved analgesia but was associated with an
improved sleep pattern and increased patient satisfaction without an
increase in the incidence of opioid related side effects such as nausea and
vomiting. Significant respiratory depression was not observed. Other studies
have shown no benefit when a background infusion was added to a patient-
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controlled analgesia regimen [Owen et al, 1989, Wu and Purcell, 1990;
Parker, Holtmann and White, 1992]. In these studies morphine consumption
was increased with no improvement in analgesia. Two studies [Sinatra et al,
1989; Parker, Holtmann and White, 1992] found an increase in opioid
induced side effects other than respiratory depression (based on the
intermittent recording of respiratory rate) with a background infusion
although arterial oxygen saturation was not monitored. The size of
background infusion used in these adult studies varied from 0.6 mg hour"1 to
1.5 mg hour"1 of morphine sulphate (pethidine 10 mg hour"1 in one) which is
equivalent to 10-20 micrograms kg"1 hour"1.
In paediatric practice, two studies have compared patient-controlled
analgesia with and without a background infusion. Berde used a background
infusion of morphine sulphate of 15 micrograms kg"1 hour'1 [Berde et al,
1991], In this study the P.C.A. only group received bolus doses of
25 micrograms kg"1 and the background infusion group received bolus doses
of 18 micrograms kg'1. The lockout time was ten minutes in both groups.
There were no differences in morphine consumption, sedation, nausea or
vomiting between the groups. Respiratory depression (assessed by
intermittent recording of respiratory rate) was not noted in any patient. The
background infusion group had lower pain scores than the P.C.A. only
group. Pain was assessed using patient and nurse visual analogue scales
whereas the study described here used a patient self-report score and this
may account for the different results of the two studies which are otherwise
similar. Another study in children [Skues et al, 1993] found that a
background infusion of 20 micrograms kg"1 hour'1 of morphine sulphate
increased opioid consumption but did not improve analgesia. It was,
however, associated with a better sleep pattern than patient-controlled
analgesia only with no increase in the incidence of side effects.
35
This is the first study to have shown an increased incidence of respiratory
depression in patients receiving a background infusion compared with those
receiving P.C.A. only. Respiratory depression has been considered to be a
risk associated with the addition of a background infusion to patient-
controlled analgesia, but has not previously been shown to occur. The
reason for this is probably that previous studies comparing patient-controlled
analgesia with and without a background infusion have relied on the
intermittent recording of respiratory rate as an indicator of respiratory
depression. This has been shown to be a late and insensitive monitor of
respiratory depression [Catley et al, 1985; Kluger et al, 1992]. Arterial
oxygen saturation while breathing air is a more sensitive monitor of
adequate ventilation [Hutton and Clutton-Brock, 1993] and it has been
suggested that continuous pulse oximetry should be routine in children
receiving systemic opioids [Morton and Gillespie, 1991], An Sp02 of 94%
corresponds to a Pa02 of about 10 kPa in healthy patients and indicates mild
hypoxia with a reduced reserve should further respiratory depression occur.
In the absence of other causes of hypoxaemia this indicates a degree of
hypoventilation which may be the result of opioid administration or of pain.
Studies which have relied on the intermittent recording of respiratory rate as
an indicator of respiratory depression and have concluded that a
background infusion does not produce respiratory depression may be falsely
reassuring. This emphasises the need for continuous monitoring and
repeated assessments by experienced staff.
The use of patient-controlled analgesia in adults is associated with an
incidence of respiratory depression. This may occur in up to 40% of patients
breathing air after upper abdominal surgery [Wheatley et al, 1992], Patients
using patient-controlled analgesia after lower abdominal surgery have been
shown to be more likely to suffer episodes of mild hypoxaemia than patients
receiving intramuscular or extradural morphine [Browse, Powar and Cohen,
1988]. Other studies have shown no difference in the incidence of
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hypoxaemia in adults using patient-controlled analgesia and those receiving
intramuscular morphine [Wheatley et al, 1992].
Despite the discouraging results of this study, there was a strong clinical
impression that subjects receiving a background infusion were more
comfortable than those with patient-controlled analgesia only and that the
use of a background infusion made the postoperative 36-48 hours less
unpleasant. This clinical impression together with the definite advantage in
terms of postoperative sleep pattern and data from other studies suggesting
benefits from the use of a background infusion encouraged further









Forty five children aged 6-14 years undergoing appendicectomy received
one of three analgesic regimens using patient-controlled analgesia with
morphine sulphate: no background infusion (Group BO); a background
infusion of 4 micrograms kg"1 hour"1 (Group B4); or a background infusion of
10 micrograms kg'1 hour'1 (Group B10). The bolus dose was
20 micrograms kg"1 and the lockout inter/al 5 minutes in all three groups.
Total morphine consumption was greater in Group B10 than in Group BO
(p < 0.01) and Group B4 (p < 0.05). There was no significant difference in
the morphine consumption of Groups B4 and B0. All three Groups self-
administered similar amounts of morphine and there were no significant
differences in pain scores or the incidence of over sedation. Group B4
suffered fewer episodes of hypoxaemia than Group B0 (p < 0.05) and Group
B10 (p < 0.01). Group B10 suffered more nausea and vomiting than Groups
B0 (p < 0.01) and B4 (p < 0.01) but there was no significant difference in the
incidence of nausea and vomiting between Groups B0 and B4. Groups B4
and B10 spent more time asleep at night than Group B0 (p < 0.05). There
was no significant difference between the groups in the amount of time spent
asleep during the day. The inclusion of a background infusion of
4 micrograms kg'1 hour'1 of morphine sulphate in a patient-controlled
analgesia regimen for children did not increase the incidence of side effects




Following the previous study, it was decided to investigate two smaller
background infusions for use with patient-controlled analgesia in children to
determine if any benefits from these could be provided without the
unacceptable increase in the incidence of side effects caused by a
background infusion of 20 micrograms kg"1 hour"1 of morphine sulphate.
Patients and Methods
The study was approved by the hospital Ethics Committee and written
informed parental consent was obtained for each subject. Forty five children
aged 6-14 years undergoing appendicectomy were recruited. Subjects were
visited before operation when the principles of using patient-controlled
analgesia were explained to the child and parents and the patient was taught
to use the trigger of the patient-controlled analgesia pump. Patients were not
reruited if they had received preoperative analgesia.
All patients received a standard general anaesthetic which comprised a
rapid sequence induction with thiopentone 5-7 mg kg"1 and suxamethonium
1 mg kg"1. The trachea was intubated and the lungs ventilated with isoflurane
0.5-2% with 70% nitrous oxide in oxygen. Neuromuscular blockade was
maintained with vecuronium 0.1 mg kg'1. Morphine sulphate 0.1 mg kg'1 was
given during the procedure. At the end of surgery, neuromuscular blockade
was antagonised with neostigmine and glycopyrrolate in appropriate doses.
In the recovery area, patients were made pain free with increments of
50 micrograms kg"1 of morphine sulphate if required.
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Before patients left the recovery area, the patient-controlled analgesia pump
(Graseby PCAS or Graseby 3300) was set up. The solution used consisted
of morphine sulphate 1 mg kg"1 diluted in 50 ml of normal saline to give a
concentration of 20 micrograms kg'1 ml'1. The syringe was attached to the
side arm of a Cardiff anti-reflux valve connected to the intravenous cannula.
Patients were randomly allocated (by means of a computer generated list) to
receive one of three different regimens. Group BO received bolus doses of
20 micrograms kg"1 with a lockout interval of 5 minutes and no background
infusion; Group B4 received bolus dose of 20 micrograms kg"1 with a lockout
interval of 5 minutes and a background infusion of 4 micrograms kg'1 hour"1
(0.2 ml hour"1); Group B10 received bolus doses of 20 micrograms kg"1 with a
lockout interval of 5 minutes and a background infusion of
10 micrograms kg "1 hour'1 (0.5 ml hour"1).
Postoperatively patients breathed air and the monitoring protocol described
previously [Morton, 1993] was used. There was continuous monitoring of
arterial oxygen saturation and hourly recordings of respiratory rate and
scores for pain, sedation and nausea and vomiting. The number of demands
made and the volume of solution used were also recorded hourly. Oximeter
readings were regarded as accurate if they lasted for several minutes,
artefact had been excluded and there was a good pulse signal displayed on
the monitor. A hypoxic episode was defined as an Sp02 of less than 94%.
P.C.A. was discontinued when there was a consistent decline in use and
patients were able to take oral analgesics.
Statistical analysis was performed as in the previous study.
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Results
The Groups were similar with regard to demographic characteristics and
timing of operation (Table 3.1).
Table 3.1. Demographic data (Mean (SD1) and timing of operation.
Group B0 Group B4 Group B10
Sex (M:F) 7:8 8:7 10:5
Age/years 10.5(1.6) 10.4 (1.9) 10.3(1.3)










Patients in all three Groups self-administered similar amounts of morphine
using the patient-controlled analgesia machine. Total morphine consumption
was significantly greater in Group B10 than in Group BO (p<0.01) and
Group B4 (p < 0.05). There was no significant difference between the total
morphine consumption in Groups BO and B4 (Table 3.2).
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Table 3.2. Details of patient-controlled analgesia use and morphine
consumption (Median (Ranged in Groups BO. B4 and B10.
Group BO Group B4 Group B10
Duration of P.C.A.
use/hours






















* Significant difference between groups B4 and B10 (p < 0.05); ** Significant
difference between Groups BO and B10 (p < 0.01).
For each patient the hourly pain scores during each four hourly interval after
operation were summed and a median pain score in each Group for each
four hourly interval calculated. Comparisons of these scores showed no
significant differences between the groups at any period (Figure 3.1).
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Figure 3.1. Comparison of Pain Scores (Median (Range)) in Groups BO, B4
and B10.
Duration of P.C.A./hours
Group B10 had significantly more hypoxic episodes (159 episodes) than
Group BO (78 episodes) (p < 0.01) and Group B4 (56 episodes) (p < 0.05).
Group BO had significantly more hypoxic episodes (78 episodes) than Group
B4 (56 episodes) (p < 0.05). The lowest Sp02 values in the three Groups
were 86-95% (mean 91%) in Group B0, 86-95% (mean 92%) in Group B4
and 86-95% (mean 90%) in Group B10.
The slowest respiratory rates recorded in the three groups were
12-18 breaths minute'1 in Group B0, 12-20 breaths minute"1 in Group B4 and
14-18 breaths minute"1 in Group B10.
Group B10 suffered significantly more vomiting (60 episodes) than Groups
B0 (20 episodes) (p < 0.01) and B4 (22 episodes) (p < 0.01). There was no
significant difference in the incidence of nausea and vomiting between
Groups B0 and B4. Antiemetics were given to one patient in Group B10.
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A sedation score of 3 was not recorded in any patient. A sedation score of 2
occurred on 22 occasions in Group BO, 19 occasions in Group B4 and on 21
occasions in Group B10 (not significant).
The amount of time spent asleep was compared in the three groups by
analysing the periods from 22:00 to 06:00 (night) and from 06:00 to 22:00
(day) separately. Groups B4 and B10 spent significantly more time asleep at
night than patients in Group B0 (p < 0.05). There was no significant
difference between Groups B4 and B10 in the amount of time spent asleep
at night and no significant differences between the Groups in the amount of
time spent asleep during the day (Table 3.3). Similar numbers of patients in
each group underwent operation at night and during the day.
Table 3.3. Comparison of the amount of time in hours spent asleep at night
and during the day in Groups B0, B4 and B10.



















* Significant difference (p < 0.05) compared with Groups B4 and B10.
Three patients in Group B10 had the background infusion discontinued
because of persistent over sedation.
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Discussion
This study showed that the use of a background infusion of 4 micrograms
kg "1 hour"1 of morphine sulphate in a patient-controlled analgesia regimen
for children after lower abdominal surgery caused no increase in side effects
compared with no background infusion and was associated with less
hypoxaemia and a better sleep pattern than patient-controlled analgesia
only. A background infusion of morphine of 10 micrograms kg"1 hour"1 was
also associated with an improved sleep pattern but was accompanied by a
significant increase in the incidence of hypoxaemia and postoperative
nausea and vomiting. Unlike a background infusion of 20 micrograms kg"1
hour'1, these smaller background infusions were not accompanied by an
increase in the incidence of over sedation.
The reason why a background infusion of 4 micrograms kg"1 hour"1 produces
less hypoxaemia than a patient-controlled analgesia regimen without a
background infusion is likely to be that the infusion produced better
analgesia and improved ventilation. This suggests that the method of
assessing pain used in this study (patient self-report) is relatively insensitive.
A specific assessment of pain on moving or coughing may have revealed
differences in analgesia between Groups BO, B4 and B10. We have
previously noted that periods of hypoxaemia often correspond with high pain
scores [Morton, 1993],
In adult studies, the use of a background infusion has been shown to
improve pain relief in two studies [Sinatra et al, 1989; McKenzie et al, 1990],
but not in others [Owen et al, 1989; Wu and Purcell, 1990; Parker, Holtmann
and White, 1992]. The studies which found no benefit from a background
infusion did not assess pain during movement. In contrast, one of the studies
which did find improved analgesia with a background infusion [Sinatra et
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al, 1989] did assess pain during movement. The other study [McKenzie et al,
1990] did not make clear if pain was assessed at rest or during movement.
Two studies [Sinatra et al, 1989; Parker, Holtmann and White, 1992] found
an increase in opioid induced side effects other than respiratory depression
such as nausea and pruritis with a background infusion although arterial
oxygen saturation was not monitored.
The results of this study indicated that the use of a background infusion with
patient-controlled analgesia in children produced benefits in terms of
postoperative sleep pattern and hypoxaemia without an increase in side
effects. It strongly suggested that a background infusion improved pain
control and that the method of scoring or assessing pain used was




Analgesia with and without a
Background Infusion of Four




Forty children aged 6-14 years undergoing appendicectomy received one of
two analgesic regimens using patient-controlled analgesia with morphine
sulphate: no background infusion (Group BO) or a background infusion of
4 micrograms kg'1 hour'1 (Group B4). The bolus dose was
20 micrograms kg "1 and the lockout interval 5 minutes in both groups. Both
Groups self-administered similar amounts of morphine sulphate. There was
no difference in the pain scores between the Groups when this was
assessed at rest but Group B4 had significantly lower pain scores when pain
was assessed during a specified movement (p < 0.01). Group B4 suffered
fewer episodes of hypoxaemia than Group BO (p < 0.001). There was no
significant difference in the incidence of nausea and vomiting or of over
sedation between Groups B0 and B4. Group B4 spent more time asleep at
night than Group B0 (p < 0.05). There was no significant difference between
the groups in the amount of time spent asleep during the day. The inclusion
of a background infusion of morphine sulphate of 4 micrograms kg"1 hour'1 in
a patient-controlled analgesia regimen for children improved analgesia and
was associated with less hypoxaemia and a better sleep pattern than no
background infusion. The background infusion did not increase the
incidence of side effects.
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Introduction
Following the previous study and the demonstration that a background
infusion of 4 micrograms kg"1 hour"1 of morphine sulphate was superior to no
background infusion in reducing the incidence of postoperative hypoxaemia,
the two regimens were compared in a similar way but with pain scoring being
carried out after a specified movement. The reason why differences between
the pain scores of the groups in the previous two studies had not been found
was presumed to be because pain was assessed at rest and that this was an
inadequately sensitive discriminator between regimens. A background
infusion of 10 micrograms kg"1 hour"1 was not included in this study because
it was felt that although it may improve analgesia, the increase in side effects
seen when it was used made it unacceptable for routine future use.
Patients and Methods
The study was approved by the hospital Ethics Committee. Forty children
aged 6-14 years undergoing appendicectomy were recruited. Subjects were
visited before operation when the principles of using patient-controlled
analgesia were explained to the child and parents and the patient was taught
to use the trigger of the patient-controlled analgesia pump. Patients were not
recruited if they had received preoperative analgesia.
All patients received a standard general anaesthetic which comprised a
rapid sequence induction with thiopentone 5-7 mg kg'1 and suxamethonium
1 mg kg"1. The trachea was intubated and the lungs ventilated with
isoflurane 0.5-2% with 70% nitrous oxide in oxygen. Neuromuscular
blockade was maintained with vecuronium 0.1 mg kg'1. Morphine sulphate
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0.1 mg kg"1 was given during the procedure. At the end of surgery,
neuromuscular blockade was antagonised with neostigmine and
glycopyrrolate in appropriate doses. In the recovery area, patients were
made pain free with increments of morphine sulphate 50 micrograms kg"1 if
required.
Before patients left the recovery area, the patient-controlled analgesia pump
(Graseby PCAS or Graseby 3300) was set up. The solution used consisted
of morphine sulphate 1 mg kg"1 diluted in 50 ml of normal saline to give a
concentration of 20 micrograms kg'1 ml"1. The syringe was attached to the
side arm of a Cardiff anti-reflux valve connected to the intravenous cannula.
Patients were randomly allocated (by means of a computer generated list) to
receive one of two different regimens. Group B0 received bolus doses of
20 micrograms kg"1 with a lockout interval of 5 minutes and no background
infusion; Group B4 received bolus dose of 20 micrograms kg"1 with a lockout
interval of 5 minutes and a background infusion of 4 micrograms kg"1 hour'1
(0.2 ml hour"1).
Postoperatively patients breathed air and the monitoring protocol described
previously [Morton, 1993] was used. There was continuous monitoring of
arterial oxygen saturation and hourly recordings of respiratory rate and
scores for pain, sedation and nausea and vomiting. Scores for pain were
noted both at rest and immediately after a specified movement (a deep
breath followed by a cough). The number of demands made and the volume
of solution used were also recorded hourly. Oximeter readings were
regarded as accurate if they lasted for several minutes, artefact had been
excluded and there was a good pulse signal displayed on the monitor. A
hypoxic episode was defined as an Sp02 of less than 94%.
P.C.A. was discontinued when there was a consistent decline in use and
patients were able to take oral analgesics.
Statistical analysis was performed as in the previous studies.
Results
The Groups were similar with regard to demographic characteristics and
timing of operation (Table 4.1).
Table 4.1. Demographic data (Mean (SD)) and timing of operation.
Group B0 Group B4
Sex (M:F) 11:9 12:8
Age/years 10.1 (1.8) 10.3 (1.9)








One patient in Group BO and three in Group B4 received a bolus of
morphine 50 micrograms kg"1 in the recovery area. These boluses are not
included in the figures for postoperative consumption of morphine. Patients
in both Groups self-administered similar amounts of morphine using the
trigger of the patient-controlled analgesia machine. Total morphine
consumption was significantly greater in Group B4 than in Group BO
(p < 0.05) (Table 4.2).
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Table 4.2. Details of patient-controlled analgesia use and morphine
consumption (Median (Range)) in Groups BO and B4.
Group BO Group B4















* Significant difference between groups (p < 0.05).
For each patient the hourly pain scores during each four hourly period after
the start of patient-controlled analgesia were added and a median score
obtained for each of these periods in each Group. There were no significant
differences between the scores of the two groups at any of these times when
assessments were made at rest but the scores in Group B4 were
significantly lower than those in Group BO (p<0.01) when assessments
were performed during movement. The mean four hourly totals for patients in
the two groups at rest are shown in Figure 4.1 and those during movement in
Figure 4.2.
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Figure 4.1. Comparison of Pain Scores (Median (Range)) in Groups BO and
B4 at Rest.
Figure 4.2. Comparison of Pain Scores (Median (Range)) in Groups BO and
B4 during Movement.
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Group BO had significantly more (p < 0.01) hypoxic episodes (100 episodes)
than Group B4 (63 episodes). The lowest Sp02 values in the two Groups
were 86-95% (mean 91%) in Group BO and 86-95% (mean 92%) in Group
B4. The slowest respiratory rate recorded was 12 breaths minute"1 in both
Groups.
There was no significant difference in the incidence of nausea and vomiting
between Groups BO and B4. A sedation score of three was not recorded in
any patient. There was no difference between the groups in the incidence of
sedation scores of 2.
The amount of time spent asleep was compared in the two groups by
analysing the periods from 22:00 to 06:00 (night) and from 06:00 to 22:00
(day) separately. Group B4 spent significantly more time asleep at night than
patients in Group B0 (p < 0.01). There was no significant difference between
the Groups in the amount of time spent asleep during the day (Table 4.3).
Similar numbers of patients in each group underwent operation at night and
during the day.
Table 4.3. Comparison of the amount of time in hours spent asleep at night and
during the day in Groups B0 and B4.















** Significant difference between groups (p < 0.01).
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Discussion
This study confirmed that the use of a background infusion of 4 micrograms
kg"1 hour'1 of morphine sulphate in a patient-controlled analgesia regimen for
children after lower abdominal surgery caused no increase in side effects
compared with no background infusion and was associated with less
hypoxaemia and a better sleep pattern than patient-controlled analgesia
only. It also demonstrated better analgesia with a background infusion than
with patient-controlled analgesia only. The improved analgesia provided by
the background infusion was only demonstrated when pain was assessed
during a movement and this emphasises the importance of performing pain
assessments in this way [Kehlet, 1994],
The lower incidence of hypoxic episodes in Group B4 may be explained as a
consequence of better analgesia resulting in less hypoventilation caused by
pain. In patients breathing air, pulse oximetry is a sensitive monitor of
adequate ventilation [Hutton and Clutton-Brock, 1993], Consideration of the
ideal alveolar gas equation shows that with an inspired oxygen concentration
of 21%, a small increase in alveolar carbon dioxide tension produces a
decrease in alveolar oxygen tension sufficient to reduce the arterial oxygen
saturation from a normal value of 97-100%. An arterial oxygen saturation of
94% corresponds to an arterial oxygen tension of about 10 kPa and is
associated with mild hypoventilation in healthy patients. This is a non¬
specific monitor of ventilation and differentiation between the possible
causes (excess opioid, pain and a problem with gas exchange) requires
examination of the patient with assessment of opioid consumption, degree of
analgesia and level of sedation. A patient who is hypoxic because of excess
opioid will be sedated while a patient in pain will be alert and unwilling to
take a deep breath and cough. The possibility of other causes of impaired
gas exchange should always be borne in mind. The fact that there was no
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difference between the groups in the incidence of over sedation suggests
that the morphine consumption in Group B4 was not excessive and that the
hypoxia seen in Group BO was a consequence of hypoventilation due to pain
rather than excessive opioid consumption. In summary, it appears that the
inclusion of a small background infusion of about 4 micrograms kg"1 hour"1 in
a patient-controlled analgesia regimen for children produces better
analgesia and a more natural sleep pattern after surgery without causing an
increase in the incidence of opioid induced side effects. A consequence of
this improved analgesia is a reduction in the incidence of hypoxic episodes
caused by hypoventilation in patients receiving a background infusion.
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CHAPTER FIVE
Comparison of Different Bolus




Forty children aged 6-14 years undergoing appendicectomy were randomly
allocated to receive one of two patient-controlled analgesia regimens with
morphine sulphate. Group B10 received bolus doses of 10 micrograms kg"1
and Group B20 received bolus doses of 20 micrograms kg"1. In both groups
there was a lockout interval of five minutes and a background infusion of
4 micrograms kg"1 hour"1. Group B20 self-administered significantly more
morphine (p < 0.01) than Group B10. There was no difference between the
pain scores of the groups at rest. Group B20 had significantly lower pain
scores (p < 0.05) during movement than Group B10. Group B10 suffered
significantly more (p<0.01) hypoxaemic episodes than Group B20. There
were no differences between the groups in the incidence of vomiting, over
sedation or time spent asleep at night.
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Introduction
Regimens described for patient-controlled analgesia in children have used
bolus doses ranging from 10 to 25 micrograms kg"1 of morphine sulphate but
there have been no comparative studies of different bolus doses in children
in terms of efficacy and side effects. This study was carried out to compare
two common bolus doses of morphine sulphate of 10 micrograms kg"1 and
20 micrograms kg"1 in a patient-controlled analgesia regimen for children.
Features of interest were efficacy, morphine consumption and the incidence
of side effects. The patient-controlled analgesia regimen used included a
background infusion of 4 micrograms kg"1 hour"1 which was shown in the
previous study to be superior to a patient-controlled analgesia regimen
without a background infusion. The study included an assessment of pain
during movement described in the previous study to improve sensitivity and
to aid discrimination between the regimens.
Patients and Methods
The study was approved by the hospital Ethics Committee and written
informed parental consent was obtained for all subjects. Forty children aged
6-14 years undergoing appendicectomy were recruited. Subjects were
visited preoperatively when the principles of using patient-controlled
analgesia were explained to the child and parents. Patients were taught to
use the trigger of the patient-controlled analgesia machine during this visit.
Patients were not recruited if they had received preoperative analgesia.
All patients received a standard general anesthetic which consisted of a
rapid sequence induction with thiopentone 5-7 mg kg"1 and suxamethonium
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1 mg kg"1. The trachea was intubated and the lungs ventilated with isoflurane
0.5-2% with nitrous oxide 70% in oxygen. Neuromuscular blockade was
maintained with vecuronium 0.1 mg kg"1. Morphine sulphate 0.1 mg kg"1 was
given during the procedure. At the end of surgery neuromuscular blockade
was reversed with neostigmine 50 micrograms kg'1 and glycopyrrolate
10 micrograms kg"1. In the recovery area patients were titrated to comfort
with boluses of morphine sulphate 50 micrograms kg"1 if required.
Before patients left the recovery area the P.C.A. machine (Graseby PCAS or
Graseby 3300) was set up. The solution used consisted of morphine
sulphate 1 mg kg"1 diluted in 50 ml of normal saline to give a concentration of
20 micrograms kg"1 ml"1. The P.C.A. machine was connected to the side arm
of an anti-reflux valve attached to the intravenous cannula. Patients were
randomly allocated (by means of a computer generated list) to receive one of
two different patient-controlled analgesia regimens. Group B10 received
bolus doses of morphine of 10 micrograms kg"1 (0.5 ml) with a lockout
interval of 5 minutes and a background infusion of 4 micrograms kg"1 hour'1
(0.2 ml hour"1); Group B20 received bolus doses of 20 micrograms kg"1 (1 ml)
with a lockout interval of 5 minutes and a background infusion of
4 micrograms kg"1 hour"1.
After operation patients breathed air. The monitoring protocol described
previously [Morton, 1993] was used with assessments of pain at rest and
during movement as described in the previous study.
Patient-controlled analgesia was discontinued when there was a consistent
decline in use and patients were able to take oral analgesics.
Statistical analysis was as described for the previous studies.
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Results
The two groups were similar demographically (Table 5.1) and with respect to
the timing of surgery.
Table 5.1. Demographic data (Mean (SD)) and timing of surgery in Groups
B10 and B20.
Group B10 Group B20
Sex (M:F) 12:8 10:10
Age/years 10.7 (1.9) 10.3 (1.4)








Patients in Group B20 self-administered significantly more morphine than
those in Group B10 (p < 0.01). There was no significant difference between
the groups in the duration of patient-controlled analgesia use or the
percentage of unsuccessful demands (demands made during the lockout
period) for analgesia (Table 5.2).
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Table 5.2. Details of P.C.A. use and morphine consumption (Median
(Range)) in Groups B10 and B20.
Group B10 Group B20









micrograms kg"1 hour"1 10.7 (1.9-25.9)** 25.5 (7.2-57)
Successful demands/% 73 (35-94) 81 (42-98)
** Significant difference (p < 0.01) between groups.
For each patient the hourly pain scores during each four hourly interval after
operation were summed and a median total pain score in each Group for
each four hourly interval calculated. There were no significant differences
between the groups at rest at any time except for the period 16-20 hours
postoperatively when the difference just reached significance at the 5% level
(Figure 5.1). Pain scores during movement in Group B20 were significantly
lower (p < 0.05) than those in Group B10 during each four hour period
except for that 44-48 hours after operation (Figure 5.2). At 44-48 hours after
operation no patient in Group B20 complained of pain at rest although some
did have pain on movement.
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Figure 5.1. Comparison of Pain Scores (Median (Range)) in Groups B10
and B20 at Rest.
Duration of P.C.A./hours
Figure 5.2. Comparison of Pain Scores (Median (Range)) in Groups B10
and B20 during Movement.
Duration of P.C.A./hours
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There were significantly more Sp02 recording of less than 94% in Group B10
(92 episodes) than in Group B20 (61 episodes) (p < 0.01).
There was no significant difference in the incidence of vomiting in the two
groups after operation (six patients in Group B10 and three patients in
Group B20).
There were no episodes of over sedation in any patient in either group. •
The amount of time that patients spent asleep was assessed by comparing
the periods from 22:00-06:00 (night) and from 06:00-2200 (day) separately.
There was no significant difference between the groups during either of
these periods (Table 5.3).
Table 5.3. Comparison of amount of time in hours spent asleep in Groups
B10 and B20.

















This study showed that when patient-controlled analgesia is used in children
a bolus dose of morphine of 10 micrograms kg"1 is associated with higher
pain scores and more hypoxic episodes than a bolus dose of 20 micrograms
kg"1. There was no difference between the groups in the incidence of other
opioid-induced side effects, sleep pattern or the percentage of unsuccessful
demands for analgesia.
The optimal bolus dose for use with patient-controlled analgesia has been
defined as the minimum dose which produces adequate analgesia
consistently without causing subjective or objective side effects [Owen et al,
1989], An inadequate bolus dose tends to result in inadequate analgesia,
while too large a bolus may cause excessive side effects. Ideally, patients
should not be required to make too frequent demands in order to obtain
adequate analgesia.
These findings are in agreement with those of adult studies where
inadequate bolus doses were associated with increased pain scores [Keeri-
Santo, 1979; Owen et al, 1990], In these studies, patients did not use the
patient-controlled analgesia machine to achieve adequate analgesia despite
the fact that there was a facility to administer more analgesic. This suggests
that patients do not always use patient-controlled analgesia to titrate
analgesic drugs to a minimum effective analgesic concentration. The time
since the previous analgesic demand and the expected benefit from a
demand in terms of analgesia appear to be important factors in the
frequency of demands made by patients.
The finding of an increased incidence of hypoxic episodes in Group B10
presumably reflects hypoventilation as a consequence of pain causing
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restriction of abdominal movement in this group. The association of
hypoxaemia with high pain scores has been noticed previously [Morton,
1993], This association may be a consequence of pain leading to inhibition
of ventilation or of a relative overdose of opioid. Since there was no excess
of over sedation in Group B20, these results suggest that the higher
incidence of hypoxaemia in Group B10 was a result of inadequate analgesia
causing hypoventilation.
The marked disparity between the sensitivity of scoring pain at rest and
during movement at discriminating between the two regimens confirms that
pain scoring at rest is inadequate and only assessments on movement
should be used to guide analgesic therapy.
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CHAPTER SIX
Comparison of Intravenous and
Subcutaneous Infusions of
Morphine Sulphate for the
Treatment of Postoperative Pain.
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Summary
The intravenous and subcutaneous routes of administration were compared
for infusions of morphine sulphate in children undergoing abdominal surgery.
Forty children aged 4-11 years underwent balanced anaesthesia with
epidural blockade and received morphine up to 30 micrograms kg"1 hour'1
postoperatively. There were no differences between the groups in opioid
consumption, pain scores or the incidence of opioid-induced side effects.
The subcutaneous route appears to be as effective and safe as the




The use of intravenous opioid infusions to treat postoperative pain in
children is a common and effective analgesic technique which has been
used for many years [Bray, 1983; Pounder and Steward, 1992], The
technique requires a second dedicated intravenous cannula for opioid
administration in addition to one for intravenous fluids and drugs.
Alternatively, the same cannula may be used for both fluids and opioid
administration but in order to avoid the risk of reflux of opioid into the
intravenous tubing with the possibility of a subsequent uncontrolled bolus,
an anti-reflux valve must be placed at the junction of the intravenous cannula
and the fluid giving set. The option of a second intravenous cannula is not
always available particularly in infants and anti-reflux valves are expensive
and make the infusion site bulky and difficult to nurse.
An alternative route of administration for opioid infusions which does not
have these disadvantages is the subcutaneous route. This has been used
extensively in terminal [Nahata, Miser and Reuning, 1984] and chronic pain
[Kerr et al, 1988] and has also been described for acute pain in adults
[Goudie et al, 1985; Hindsholm et al, 1993], The subcutaneous route has
been used for the administration boluses of opioid in children [Wandless and
Lavies, 1989] and the efficacy of subcutaneous infusions of morphine has
been demonstrated [McNicol, 1993], For this technique to become
widespread and accepted it must be shown to have equal efficacy to the
traditional intravenous route with the same or a lower incidence of side
effects. The intravenous and subcutaneous routes of administration have not
been compared in children and this study was designed to compare them in
children undergoing abdominal surgery in terms of efficacy and the
incidence of side effects.
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Patients and Methods
The study was approved by the hospital Ethics Committee. Forty children
aged 4-11 years undergoing abdominal surgery with combined general
anaesthesia and epidural blockade were studied. Exclusion criteria included
contraindications to epidural blockade and significant hepatic or renal
impairment. Patients were premedicated with EMLA cream at least one hour
preoperatively and anaesthesia was induced with propofol 3-4 mg kg"1 and
vecuronium 0.1 mgkg"1. Following endotracheal intubation, the lungs were
ventilated with isoflurane 0.5-2% with 70% nitrous oxide in oxygen. Patients
were then turned into the lateral position and a single epidural injection of
0.8 ml kg"1 of 0.25% bupivacaine (2 mg kg"1) (maximum 20 ml) given. At the
end of surgery neuromuscular blockade was reversed with neostigmine and
glycopyrrolate in appropriate doses and the trachea extubated.
Patients were randomised to receive either an intravenous or a
subcutaneous infusion of morphine sulphate postoperatively. In the
intravenous group (Group IV) a second 22G cannula was sited intravenously
on the same side as the cannula used for induction. In the subcutaneous
group (Group SC) a 24G cannula was sited subcutaneously over the deltoid
muscle on the same side as the intravenous cannula. Morphine infusions
were started in the recovery area.
In Group IV the solution used consisted of morphine sulphate 1 mg kg"1
diluted in 50 ml of 0.9% saline to give a concentration of 20 micrograms kg"1
ml'1. The intravenous infusion was commenced at a rate of 1 ml hour"1
(20 micrograms kg"1 hour1). In Group SC the solution used consisted of
1 mg kg"1 of morphine sulphate diluted in 20 ml of 0.9% saline to give a
concentration of 50 micrograms kg"1 ml"1. This was commenced at
0.4 ml hour"1 (20 micrograms kg"1 hour"1).
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Postoperatively patients breathed air and the monitoring protocol described
previously [Morton, 1993] was used with assessments of pain at rest and
during movement. Morphine sulphate was infused at a maximum rate of
30 micrograms kg"1 hour"1 and further bolus doses of morphine sulphate
50 micrograms kg"1 were available if required.
Infusions were discontinued when there was a consistent decline in opioid
requirements and patients were able to take oral analgesics.
Statistical analysis was performed as in the previous studies.
Results
The two groups were similar with respect to demographic characteristics,
surgical procedures and the duration of surgery (Table 6.1).
Table 6.1. Demographic data (Mean (SD)) and surgical characteristics of
Groups IV and SC.
Group IV Group SC
Male:Female 9:11 12:8
Age/years 8.4 (2.2) 8.8 (2.2)
Weight/kg 27.1 (6.3) 25.3 (5.8)
Gastrointestinal/Genitourinary 9:11 11:9
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The duration of infusion analgesia and the total opioid consumption were
similar in the two groups (Table 6.2).
Table 6.2. Details of opioid consumption and duration of infusion (Median
(Range)) in Groups IV and SC.
Group IV Group SC








For each patient the hourly pain scores during each four hourly interval after
operation were summed and a median total pain score in each Group for
each four hourly interval calculated. Comparisons of these scores showed
no significant differences between the groups during any period (Figure 6.1).
There were no significant differences between the groups at any point Four
children in Group IV and three children in Group SC received one
supplementary bolus of morphine for inadequate analgesia at the maximum
infusion rate.
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There were no differences between the Groups in the incidence of vomiting,
over sedation or in the number of hypoxic episodes (Table 6.3).
Table 6.3. Episodes of hypoxia, over sedation and postoperative vomiting in
Groups IV and SC.
Group IV Group SC
Hypoxia 32 24
Over sedation 3 5
Vomiting 39 29
Six cannulae in Group IV and one cannula in Group SC needed to be
replaced during the opioid infusion.
Discussion
This study demonstrated that the subcutaneous route of administration is as
effective as the intravenous route for the infusion of opioids in children after
elective surgery. Although subcutaneous administration has been shown to
provide analgesia [McNicol, 1993] in children it has not previously been
shown to be as effective as the intravenous route. The fact that equivalent
analgesia can be provided by this route with similar doses of morphine and
no increase in the incidence of side effects suggests that this technique will
prove to be a useful in this group of patients. The advantages of avoiding the
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need for a dedicated intravenous cannula or for an anti-reflux valve are
considerable in small children. Use of the subcutaneous route for opioid
infusions is likely to reduce the practical difficulties associated with the
provision of this form of analgesia in children.
It should be remembered that the subjects in this study were elective
normovolaemic patients with normal cardiac output. The subcutaneous route
would be contraindicated in patients with or at risk of developing poor
peripheral perfusion where there would be a risk of accumulation of opioid at
the infusion site with poor analgesia and subsequent absorption of this depot










Sixty children aged 6-14 years undergoing appendicectomy were randomly
allocated to receive one of two P.C.A. regimens with morphine sulphate.
Group IV received intravenous patient-controlled analgesia with a bolus
dose of 20 micrograms kg"1 and a background infusion of 4 micrograms kg"1
hour"1 while Group SC received patient-controlled analgesia by the
subcutaneous route with a bolus dose of 20 micrograms kg'1 and a
background infusion of 5 micrograms kg"1 hour'1. In both groups there was a
lockout interval of 5 minutes. Group SC self-administered significantly less
morphine (p < 0.05) and had a significantly greater (p < 0.01) percentage of
valid demands for analgesia than Group IV. There were no differences
between the pain scores of the two groups at rest or during movement.
Group IV suffered significantly (p < 0.01) more hypoxic episodes than Group
SC. There were no differences between the groups in the incidence of over
sedation or postoperative nausea and vomiting. Subcutaneous patient-
controlled analgesia appears to be as effective and safe as intravenous
patient-controlled analgesia. By giving patients feedback on the occurrence
of valid demands for analgesia subcutaneous patient-controlled analgesia
may produce more effective and appropriate use of the machine.
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Introduction
Following the demonstration that the subcutaneous route of administration is
as effective as the intravenous route for the administration of opioid
infusions in selected children, it was decided to investigate this route for the
administration of patient-controlled analgesia. Both groups received a small
background infusion which had previously been shown to be superior to a
patient-controlled analgesia regimen with no background infusion.
Patients and Methods
The study was approved by the hospital Ethics Committee and written
informed parental consent was obtained for each subject. Sixty children
aged 6-14 years undergoing appendicectomy were studied. Patients were
visited before operation when the principles of using patient-controlled
analgesia were explained to the child and parents. Patients were taught to
use the trigger of the patient-controlled analgesia machine during this visit.
Patients were not studied if they had received analgesia before operation.
All patients received a standard general anaesthetic which comprised a
rapid sequence induction with thiopentone 5-7 mg kg"1 and suxamethonium
1 mg kg"1. The trachea was intubated and the lungs ventilated with 0.5-2%
isoflurane in 70% nitrous oxide in oxygen. Neuromuscular block was
maintained with vecuronium 0.1 mg kg"1. Morphine sulphate 0.1 mg kg"1 was
given during the procedure. At the end of surgery neuromuscular block was
antagonised with neostigmine and glycopyrrolate in appropriate doses. In
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the recovery area patients were titrated to comfort with bolus doses of
morphine 50 micrograms kg"1 if required.
Before patients left the recovery area the P.C.A. pump (Graseby PCAS or
Graseby 3300) was set up. Patients were randomly allocated (by means of a
computer generated list) to receive one of two different patient-controlled
analgesia regimens. One group received intravenous patient-controlled
analgesia (Group IV) and the other group received patient-controlled
analgesia by the subcutaneous route (Group SC). In Group IV the solution
used consisted of morphine sulphate 1 mg kg"1 diluted in 50 ml of normal
saline to give a concentration of 20 micrograms kg"1 ml"1. The syringe was
attached to the side arm of a Cardiff one way anti-reflux valve connected to
the intravenous cannula. This group received bolus doses of
20 micrograms kg"1 (1 ml) with a lockout interval of 5 minutes and a
background infusion of 4 micrograms kg"1 hour"1 (0.2 ml hour"1).
In Group SC, a 22G cannula was sited subcutaneously over the deltoid
muscle of the same non-dominant arm as the intravenous cannula. This
cannula was flushed with 0.5 ml of 0.9% saline and secured with Elastoplast
tape. The syringe was attached to this cannula. In Group SC, the solution
used consisted of morphine sulphate 1 mg kg"1 diluted in 20 ml of normal
saline to give a concentration of 50 micrograms kg"1 ml'1. This group
received bolus doses of 20 micrograms kg"1 (0.4 ml) with a lockout interval of
5 minutes and a background infusion of 5 micrograms kg"1 hour"1
(0.1 ml hour'1). This background infusion differed slightly from that used in
Group IV because it was not possible to give the same background infusion
with the dilution of morphine used.
After operation patients breathed air and the monitoring protocol described
previously was used [Morton, 1993], Patients were asked to quantify the
delay between pressing the trigger of the patient-controlled analgesia
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machine and the onset of analgesia. Patients were also asked about the
presence of pain or discomfort at the site of the subcutaneous cannula and
its relation to pressing the trigger of the patient-controlled analgesia
machine. Patient-controlled analgesia was discontinued when there was a
consistent decline in use and patients were able to take oral analgesics. At
the discontinuation of subcutaneous patient-controlled analgesia the
cannula was removed and the site inspected.
Statistical analysis was performed as in the previous studies.
Results
The two groups were similar with regard to demographic characteristics
(Table 7.1).
Table 7.1. Demographic data (Mean (SD)) of patients in Groups IV and SC.
Group IV Group SC
Sex (M:F) 17:13 14:16
Age/years 10.7 (1.9) 10.9 (1.6)
Weight/kg 39.2 (11.4) 36.6 (8.9)
Patients in Group IV self-administered significantly more morphine than
those in Group SC (p < 0.05). Group SC had a significantly greater
percentage of valid demands than Group IV (P < 0.01) (Table 7.2).
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Table 7.2. Details of patient-controlled analgesia use and morphine
consumption (Median (Range)) in Groups IV and SC.
Group IV Group SC















% Valid demands 75 (23-100) 92 (68-100)**
* Significant difference between groups (p < 0.05); ** Significant difference
between groups (p < 0.01).
Pain scores were compared by calculating the median total pain score (at
rest and during movement) during each four hour period after operation and
comparing the groups during each of these periods. Figure 7.1 shows the
pain scores in the two groups at rest and Figure 7.2 shows the scores in the
groups during movement. There were no significant differences between the
groups at any of these times.
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There were significantly more Sp02 readings of less than 94% in Group IV
than in Group SC (p<0.01) (Table 3). The lowest values recorded were
85% in Group IV and 87% in Group SC.
There were no significant differences between the groups in the incidence of
postoperative nausea and vomiting (PONV) or of over sedation (Table 7.3).
There were no sedation scores of 3 in any patient.
Table 7.3. Episodes of hypoxia, over sedation and postoperative vomiting in
Groups IV and SC.
Group IV Group SC
Hypoxia 193 123 **
Vomiting 95 65
Over sedation 10 8
** Significant difference between groups (p < 0.01).
Twenty eight patients in Group SC were aware of bolus infusions shortly
after making a demand. Five patients in Group SC complained of pain at the
cannulation site during bolus dose infusion. In all of these five patients,
bolus doses stopped being painful after several hours of patient-controlled
analgesia use. Four patients in Group IV were able to feel bolus dose
infusions and no patients in this group complained of pain during bolus dose
infusion.
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In Group SC, 9 patients had a localised erythematous flare at the site of
subcutaneous cannulation which started soon after the commencement of
patient-controlled analgesia. In all cases this faded after several hours. In
Group SC, there were no problems at the cannulation site after removal of
the cannulae.
Discussion
This study has shown that subcutaneous patient-controlled analgesia
appears to be as effective and safe for the treatment of postoperative pain
as intravenous patient-controlled analgesia. It also suggests that the
subcutaneous route for patient-controlled analgesia may have advantages
over the intravenous route. There was a lower consumption of morphine in
Group SC (in patients undergoing the same procedure) associated with a
higher proportion of valid demands for analgesia. This was possibly because
of the fact that with subcutaneous patient-controlled analgesia patients were
aware of bolus infusions and that the demand for analgesia had been
successful. Because of this, patients expected the demand to produce
analgesia and tended not to make further invalid demands during the lockout
period. The usefulness of a positive feedback mechanism to the patient to
indicate that a demand for analgesia has been successful has been noted
previously [Johnson and Luscombe, 1992; Owen et al, 1993] and patient-
controlled analgesia pumps which produce different sounds in response to
valid and invalid demands are being developed. It should be remembered
that Group SC received a background infusion of 5 micrograms kg"1 hour"1
compared with 4 micrograms kg*1 hour"1 in Group IV and this may have been
partly responsible for the reduced requirement for self-administered
morphine in Group SC. This would not, however, explain the reduction in
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total morphine consumption in Group SC compared with Group IV or the
higher percentage of valid demands.
The lower incidence of hypoxic episodes in Group SC may be explained by
several possible mechanisms. The lower morphine consumption during
subcutaneous patient-controlled analgesia may result in less respiratory
depression than would otherwise be the case. Improved analgesia as a
consequence of more appropriate analgesic administration in response to
pain may have reduced the incidence of hypoventilation caused by pain
(although this should have been reflected in differences in the pain scores of
the groups). Alternatively, differences in the pharmacokinetics of the two
routes of administration may produce lower peak concentrations of morphine
if boluses are given subcutaneously rather than intravenously. Limited data
concerning the absorption of morphine during intravenous and
subcutaneous infusions in adults [Waldmann et al, 1984] and children
[Morton et al, 1995; Watson et al, 1995] suggest that both routes are equally
effective in normovolaemic patients but there are no data concerning
absorption after intermittent bolus dose administration. The fact that there
was no difference between the groups in the incidence of over sedation
suggests that the morphine consumption in Group IV was not excessive.
Although the subcutaneous route of administration is very satisfactory for
infusion analgesia in chronic and terminal pain and also acute pain there is
concern that the absorption of bolus doses is so slow as to make it
unsuitable for use with patient-controlled analgesia. In this study, this proved
not to be the case and in all patients the delay to feeling an analgesic effect
after making a demand was in the order of a few minutes. We did not
attempt to assess this interval accurately because of difficulties for children
judging time accurately during the postoperative period.
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In summary, subcutaneous patient-controlled analgesia appears to be as
effective and safe as intravenous patient-controlled analgesia and it may
offer advantages over the intravenous route by providing feedback on
successful demands for analgesia and enhancing appropriate use of the
pump. It should be restricted to patients who are normovolaemic and unlikely
to suffer impaired cardiac output for any reason.
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CHAPTER EIGHT
Prevention of Postoperative Nausea





Forty children aged 6-14 years undergoing abdominal surgery under general
anaesthesia with epidural blockade were studied. Subjects were randomly
allocated to receive transdermal hyoscine (loading dose 140 micrograms,
followed by 5 micrograms hour"1) or placebo for the duration of postoperative
analgesia with patient-controlled analgesia using morphine sulphate. There
was a significant (p < 0.001) reduction in the incidence of postoperative
nausea and vomiting in the treated group compared with the placebo group
during the first 48 hours after operation. The treated group also had a




Postoperative nausea and vomiting occurs (PONV) in up to 80% of patients
in many series [Palazzo and Strunin, 1984; Clarke. 1984; Kortilla et al, 1979;
Kapur, 1991; Uppingtom et al, 1986], The causes include the effects of
premedicant drugs, anaesthetic agents, postoperative analgesics (especially
opioids), the surgical procedure and the susceptibility of the patient.
Postoperative nausea and vomiting appears to be a significant problem in
patients who use patient-controlled analgesia for postoperative pain relief
[Wheatley et al, 1991], Postoperative nausea and vomiting is also a
significant problem in children using patient-controlled analgesia [Lawrie et
al, 1990; Gaukroger et al, 1989; Rodgers et al, 1988; Broadman et al, 1989]
and may be very distressing for a number of children who use this form of
postoperative analgesia.
Several agents with different modes of action are commonly used to treat
postoperative nausea and vomiting, including phenothiazines,
butyrophenones, antihistamines, dopamine antagonists and anticholinergics.
Children are sensitive to the extrapyramidal effects of some of some of these
drugs [Bateman, 1991],
The anticholinergic agent, hyoscine, has been shown to have an antiemetic
effect when given intramuscularly [Dundee et al, 1964; Clark et al, 1965],
There is also a preparation of hyoscine in the form of a plaster for
transdermal application (Scopoderm TTS {Ciba}) which contains 1.5 mg of
hyoscine. This releases 140 micrograms of hyoscine soon after application
followed by 5 micrograms hour"1 for up to 72 hours while the plaster is in
place giving an average absorption rate of hyoscine of 500 micrograms in 72
hours. The preparation has been shown to have a significant antiemetic
effect in motion sickness [Cronin et al, 1982; Price et al, 1981; van Marion et
90
al, 1985], Transdermal application of hyoscine offers potential advantages in
the prevention of postoperative nausea and vomiting. It produces steady low
plasma levels of hyoscine [Muir and Metcalf, 1983] and avoids the problems
of a short half-life, brief duration of action and high peak plasma
concentrations which occur after intramuscular injection. In paediatric
practice the avoidance of intramuscular injections is a particular advantage.
This study was a prospective, placebo controlled, double blind assessment
of the efficacy of transdermal hyoscine in preventing postoperative nausea
and vomiting in children using patient-controlled analgesia with morphine
sulphate after abdominal surgery.
Patients and Methods
The study was approved by the hospital Ethics Committee and written
informed parental consent was obtained for each subject. Forty children
aged 6-14 years undergoing abdominal surgery were recruited. Exclusion
criteria included inability to operate a patient-controlled analgesia machine,
contraindications to epidural analgesia and the use of centrally acting
antiemetic drugs within the previous week. Before operation subjects were
instructed in the principles and use of patient-controlled analgesia.
A standard anaesthetic technique was used. Premedication consisted of
diazepam 0.3 mg kg"1 orally 2 hours before operation. Anaesthesia was
induced with propofol 3-4 mg kg"1 (plus lignocaine 0.2 mg kg"1) and
vecuronium 0.1 mg kg"1. The trachea was intubated and the lungs ventilated
with isoflurane 0.5-2% with 70% nitrous oxide in oxygen. The patient was
then turned into the lateral position and a 'single shot' epidural injection of
0.25% bupivacaine 0.8 ml kg'1 (2 mg kg"1) (maximum 20 ml) given at an
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appropriate dermatomal level for the proposed surgery. At the end of surgery
neuromuscular blockade was reversed with neostigmine and glycopyrrolate
in appropriate doses. Patients were titrated to comfort in the recovery area
with boluses of 50 micrograms kg"1 of morphine sulphate if required.
Patients were randomly allocated (by means of a computer generated list) to
two groups of twenty patients. Group H received a hyoscine patch and
Group P received a placebo patch. After induction of anaesthesia and before
the start of surgery, patients in Group H had a hyoscine patch applied to the
skin in the left postauricular area and this was covered with an Elastoplast
dressing. Patients in Group P had the dressing alone applied to the area.
Before patients left the recovery area the P.C.A. machine (Graseby
P.C.A.S.) was connected. The solution used consisted of morphine sulphate
1 mg kg"1 diluted in 50 ml of normal saline to give a concentration of
20 micrograms kg"1 ml"1. The syringe was attached to the side arm of a
Cardiff anti-reflux valve connected to the intravenous cannula. The patient-
controlled analgesia settings used were a bolus dose of 1 ml
(20 micrograms kg"1), with a lockout interval of 5 minutes. A background
infusion was not used.
After operation patients breathed air and. the postoperative monitoring
protocol described previously was used [Morton, 1993],
Subjects were questioned on each postoperative day for the presence of dry
mouth and blurred vision. All assessments were made by an observer
blinded to the treatment groups.
Rectal prochlorperazine was prescribed as an antiemetic if required in both
groups. Patient-controlled analgesia was discontinued when there was a
consistent decline in use and patients were able to take oral analgesics.
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Hyoscine and placebo patches were removed at the time patient-controlled
analgesia was discontinued.
Statistical analysis was performed as described for the previous studies.
Results
Patient data are shown in Table 8.1. The two groups were similar in all
respects.
Table 8.1. Demographic data (Mean (SD)) and details of procedures in
Groups H and P.
Group H Group P
Sex (M:F) 6:14 7:13
Age/years 11.1 (2.1) 10.2 (1.8)
Weight/kg 39.5 (13.4) 36.9 (11.9)
Duration of anaesthesia/minutes
Median (Range) 95 (65-210) 90 (55-210)
Duration of surgery/minutes









Morphine consumption and the duration of P.C.A. use was similar in the two
groups (Table 8.2).
Table 8.2. Details of P.C.A. use and morphine consumption (Median
(Range)) in Groups H and P.
Group H Group P








Pain scores in the groups were compared by calculating the median total
pain score during each four hourly period after the start of P.C.A. in each
Group and comparing these for each period. There were no significant
differences between the Groups at any time (Figure 8.1).
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There was a significant reduction in the incidence of postoperative nausea
and vomiting (defined as a nausea score other than 0) in Group H compared
with Group P (p < 0.001) during the period of patient-controlied analgesia
use (Table 8.3). There was also a significant reduction in the number of
patients who complained of postoperative nausea and vomiting at any time
in Group H compared with Group P (p < 0.05) (Table 8.3). Six patients in
Group P and 3 patients in Group H vomited on one or more occasions.
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Table 8.3. Comparison of numbers of episodes of PONV and the numbers of
patients suffering from PONV in Groups H and P.
Group H Group P
Episodes of PONV 29 69***
Patients with PONV at
any time
6 14*
* Significant difference between groups (p < 0.05); *** Significant difference
between groups (p < 0.001).
When the antiemetic effect of hyoscine was analysed for each twenty four
hour period of use there was a significant (p < 0.01) antiemetic effect during
the first twenty four hours of use; a significant (p < 0.01) effect during the
second twenty four hours of use and no significant effect during the third
twenty four hour period of use (Table 8.4).
Table 8.4. Comparisons of the antiemetic effects of hvoscine during each
twenty four hour period after operation.
Episodes of PONV Group H Group P
First 24 hours 20 45**
Second 24 hours 8 17**
Third 24 hours 1 5
** Significant difference between groups (p < 0.01).
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Two patients in Group P received one dose each of prochlorperazine during
patient-controlled analgesia use.
There was no significant difference between the groups in the number of
occasions when a Sp02 reading of less than 94% occurred (Table 8.5). One
patient in Group H was excluded from this analysis because he was
receiving supplementary oxygen having suffered a pneumothorax during a
nephrectomy. The number of occasions when subjects were considered to
be over sedated (sedation score of 2 or 3) was significantly higher in Group
H than in Group P (p < 0.02). There were no sedation scores of 3 in either
group (Table 8.5).
There was no significant difference in the incidence of dry mouth during the
first postoperative day but during the second and third postoperative days
there was a significantly higher (p < 0.01) incidence of this symptom in
Group H (Table 8.5). There was no significant difference between the groups
in the incidence of blurred vision (Table 8.5).
Table 8.5. Comparison of incidence of side effects in Groups H and P.
Group H Group P
Hypoxia 136 117
Over sedation 32 15*
Dry mouth 19 9**
Blurred vision 1 0
* Significant difference between groups (p < 0.02); ** Significant difference
between groups (p < 0.01).
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One subject in Group H suffered hallucinations when the hyoscine patch had
been in place for 36 hours. This responded quickly to removal of the patch
and cleaning the skin at the application site. There were no local reactions at
the site of patch application in any patients.
Discussion
This study has demonstrated a significant antiemetic effect of transdermal
hyoscine in children using patient-controlled analgesia. Children generally
suffer less from postoperative nausea and vomiting than adults when
patient-controlled analgesia is used with the incidence varying from 4-35%
[Lawrie et al, 1990; Gaukroger et al, 1989; Rodgers et al, 1988; Broadman et
al, 1989] compared with 38-82% in adults [Semple et al, 1992; Harris et al,
1991, Wheatley et al, 1991], Although the majority of nausea scores in our
placebo group were 0, this reflects the frequency of observation. More than
67% of patients in Group P suffered postoperative nausea or vomiting.
Other studies on the efficacy of transdermal hyoscine in the prevention of
postoperative nausea and vomiting are contradictory. Two studies [Semple
et al, 1992; Harris et al, 1991] used transdermal hyoscine in combination
with patient-controlled analgesia after intra-abdominal gynaecological
surgery without regional blocks. The first of these [Semple et al, 1992] found
a reduction in the incidence of postoperative nausea and vomiting
immediately and on the third day after operation. The treated group required
half the number of supplementary doses of antiemetic as those in the
placebo group in this study. Preoperative opioids were omitted and fentanyl
was given during operation. The other study [Harris et al, 1991] found a
significant antiemetic effect of transdermal hyoscine compared with placebo
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and a reduced need for supplementary droperidol in the treated group.
There was no opioid premedication and fentanyl was given during surgery.
Two studies [Loper et al, 1989; Kotelko et al, 1989] in patients receiving
extradural morphine for postoperative analgesia showed that transdermal
hyoscine had a significantly greater antiemetic effect than placebo, with a
reduced requirement for supplementary antiemetics. One of these [Loper et
al, 1989] studied patients undergoing intra-abdominal gynaecological
surgery with general anaesthesia and intraoperative extradural blockade and
the other [Kotelko et al, 1989] was in women undergoing Caesarean section
under extradural blockade.
Transdermal hyoscine has also been found to be effective in orthopaedic
and plastic surgery [Wilkinson et al, 1989], In contrast, Koski and colleagues
found no effect of transdermal hyoscine on the incidence of postoperative
nausea and vomiting in female patients although this study was poorly
controlled [Koski et al, 1990], Tigerstedt [Tigerstedt et al, 1988] found
transdermal hyoscine was no more effective than placebo or intraoperative
droperidol in preventing postoperative nausea and vomiting. This study
included a variety of surgical procedures, the hyoscine patches were only
applied 50 minutes before surgery, opioid premedication was used in
addition to intraoperative fentanyl and postoperative intramuscular opioids
were given.
The use of propofol as an induction agent, followed by inhalational agents,
causes less postoperative nausea and vomiting than thiopentone [Boysen et
al, 1989; Doze et al, 1988; Watcha et al, 1991] and it has been suggested
that propofol has antiemetic effects [McCollum et al, 1988], Avoidance of
preoperative opioid premedication and intraoperative opioids is likely to
reduce total opioid consumption. An extradural block provides analgesia into
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the postoperative period and reduces the requirements for patient-controlled
analgesia with morphine in the early postoperative period.
It has been suggested that transdermal hyoscine should be applied several
hours before surgery [Rowbotham, 1992] so that therapeutic plasma
concentrations are attained perioperatively. It is possible that a more
pronounced antiemetic effect would have been found if we had done this
rather than apply the patches at the induction of anaesthesia.
The finding of an increased incidence of dry mouth in Group H is in keeping
with the results of several previous studies [Harris et al, 1991; Kotelko et al,
1989; Wilkinson et al, 1989; Koski et al, 1990] and is a recognised common
side effect of hyoscine. The finding that there was no difference between the
groups in the incidence of dry mouth during the first postoperative day
probably reflects the high incidence of this in all patients soon after
abdominal surgery as a result of of preoperative fasting and endotracheal
intubation.
Other studies have reported visual disturbances induced by hyoscine used
both for travel sickness [Cronin et al, 1982] and for postoperative nausea
and vomiting [Uppington et al, 1986; Semple et al, 1992; Koski et al, 1990;
Tigerstedt et al, 1988; Bailey et al, 1990], Our finding of no difference
between the groups may reflect a lower incidence of this complication in
children or the fact that children are less bothered by this symptom than
adults. Psychosis has been reported after transdermal hyoscine [MacEwan
et al, 1985; Clissold and Heel, 1985] in children and in adults. It is unusual
and easily treated by removing the patch and cleaning the skin.
In summary, transdermal hyoscine has a useful antiemetic effect in children
using patient-controlled analgesia after abdominal surgery but its use is




The work described in this thesis is the largest body of published work
describing clinical experience with patient-controlled analgesia in children.
There are over 11,000 hours of patient use in this series with continuous
pulse oximetry while breathing air and hourly assessments of efficacy and
the incidence of side effects. In particular, the routine use of continuous
pulse oximetry to detect mild hypoventilation is unique.
In terms of efficacy, patient-controlled analgesia has been previously
demonstrated to be superior to intermittent bolus dose administration of
opioids. The work described here has supported this by demonstrating
consistently low pain scores in children undergoing abdominal surgery. It
appears that the use of a small background infusion in the region of
4-5 micrograms kg'1 hour"1 of morphine sulphate improves the efficacy of
patient-controlled analgesia in children by reducing the occurrence of
hypoventilation caused by abdominal pain. Rather than increasing the
incidence of side effects a background infusion of appropriate size reduces
the incidence of hypoxic episodes, has no effect on nausea and vomiting
and encourages a natural pattern of sleep with less time spent awake at
night than if no background infusion is used. The subcutaneous route of
administration is as effective as the intravenous route in appropriately
selected patients and has the potential advantages of avoiding the need for
a dedicated cannula or an anti-reflux valve. In the event of a technical
problem which could cause siphonage of the syringe contents into the
patient, use of the subcutaneous route of administration may prevent this
happening. This would not be the case if the infusion pump were
programmed incorrectly or malfunctioned and infused a large volume of
opioid under high pressure.
It should be emphasised that these observations apply only to children
undergoing abdominal surgery and that the situation when children use
patient-controlled analgesia after orthopaedic or other peripheral surgery
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may be different. In these circumstances hypoventilation as a consequence
of pain would not be expected to occur and the benefits of a background
infusion in reducing the incidence of hypoxic episodes found in this series
may not be seen. Since non-abdominal surgery is often associated with a
lower incidence of postoperative nausea and vomiting than abdominal
surgery, particularly urgent abdominal surgery such as appendicectomy, it
may be the case that the use of a small background infusion may increase
the incidence of nausea and vomiting after non-abdominal surgery as was
seen with the larger background infusion rates. Because of these
considerations it is important not to extrapolate the findings of this work too
generally.
The most serious potential side effect of opioid based analgesic techniques
is ventilatory depression which may occur for one or more of several reasons
described in Chapter 1. There were no episodes of life threatening
respiratory depression in this series. The lowest Sp02 recorded was 83%
and the lowest respiratory rate 7 breaths/minute. The majority of episodes of
hypoventilation detected by pulse oximetry were mild and associated with
Sp02 values of over 90%. The very low incidence of more severe hypoxic
episodes is reassuring and may indicate that the use of opioid based
analgesic techniques in healthy children has a wider margin of safety than in
an adult population where a significant incidence of hypoxic episodes can be
demonstrated when they are used. There have, however, been cases in the
hospital of life threatening episodes of respiratory depression associated
with the use of patient-controlled analgesia when parents have ignored
instructions and administered morphine to children using the trigger of the
patient-controlled analgesia machine. Similar episodes are well described in
individual case reports and anecdotal evidence. These together with the
other potential causes of an opioid overdose mean that even though the
basic concept and technique of patient-controlled analgesia may be safe in
children, a monitoring protocol which consistently detects problems at an
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early stage must be used in all cases. This should include the use of pulse
oximetry while breathing room air although the most important component is
the frequent observation of the patient by an appropriately trained nurse with
medical support available if required.
The most troublesome side effect of opioids is probably nausea and
vomiting. The incidence of this symptom was increased by the use of
background infusions of 20 micrograms kg"1 hour"1 and 10 micrograms kg"1
hour"1 of morphine but not by one of 4 micrograms kg"1 hour"1. When a
specific attempt was made to reduce the incidence of postoperative nausea
and vomiting by using transdermal hyoscine in elective patients receiving
epidural blockade this was successful but was judged to cause an
unacceptable degree of sedation. Because of this limitation the use of
transdermal hyoscine has not become common in the hospital since it
interferes with a valuable monitor of excessive opioid administration.
Pruritis is described as a common side effect in patients receiving morphine.
This was not formally looked for or recorded in this series but was
spontaneously complained of by less than five patients.
The burden of preoperative explanation and tuition to patients and parents
and postoperative supervision to ensure appropriate and safe use of the
patient-controlled analgesia machines was considerable in this series of
patients. In the absence of dedicated staff and time to do this there would be
many patients in whom a straightforward infusion is preferable to patient-
controlled analgesia. This would be particularly so in smaller children aged
from 5-8 years where poorly supervised patient-controlled analgesia is
associated with inappropriate use of the pump resulting in poorer analgesia
and more complications and problems than an infusion.
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COMPARISON OF PATIENT-CONTROLLED ANALGESIA WITH
AND WITHOUT A BACKGROUND INFUSION AFTER LOWER
ABDOMINAL SURGERY IN CHILDREN
E. DOYLE, D. ROBINSON AND N. S. MORTON
SUMMARY
Forty children aged 6-12 yr undergoing appendic-
ectomy were allocated randomly to receive post¬
operative i.v. morphine by a patient-controlled
analgesia (PCA) system (bolus dose 20 gg kg
with a lockout interval of 5 min) or the same PCA
with a background infusion of morphine
20 pg kg~1 h~1. Patients breathed air and oxygen
saturation was monitored by continuous pulse
oximetry. Scores for pain, sedation and nausea
were recorded hourly. Patients with PCA+ back¬
ground infusion received significantly more mor¬
phine than those with PCA only. Both groups self-
administered similar amounts ofmorphine using the
PCA machine. There were no significant differences
in the pain scores of the two groups. Patients with
PCA + background infusion suffered more nausea
fP < 0.01), more sedation (? < 0.05) and hypox-
aemia (P < 0.001) than those with PCA only. They
also had a better sleep pattern than those with PCA
only. (Br. J. Anaesth. 1993; 71 : 670-673).
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Patient-controlled analgesia (PCA) has been used in
children since 1987 [1], initially in adolescents and
later in selected children as young as 5 yr [2-6]. The
drug used most commonly has been morphine with
a bolus dose of 10-25 pg kg-1 and a lockout interval
of 5-15 min. A continuous background infusion has
been used in some studies. These studies were
empirical and there are few which have compared
different PCA regimens in paediatric practice.
The addition of a background infusion to PCA
may improve the quality of analgesia provided [7] by
reducing the decrease in plasma concentrations of
opioid during sleep. However, a fixed infusion may
reduce the inherent safety of PCA by continuing to
deliver opioid to a patient who has adequate analgesia
[8], The use of a background infusion may also result
in larger amounts of opioid being administered and
an increase in the incidence of opioid-induced side
effects [9].
This study was carried out to assess the effect on
postoperative analgesia, sedation, ventilatory fre¬
quency, nausea and vomiting, sleeping pattern and
arterial oxygen saturation («Sp02) of adding a back¬
ground infusion of morphine to a PCA regimen in
children.
PATIENTS AND METHODS
The study was approved by the hospital Ethics
Committee and written informed parental consent
was obtained. We studied 40 children aged 6-12 yr
undergoing appendicectomy. The patients were
visited before operation when the principles of using
PCA were explained to the child and parents, and
the patients were taught how to use the trigger of the
PCA machine.
Patients were studied only if they had not received
preoperative analgesia. All patients received a stan¬
dard general anaesthetic which consisted of a rapid
sequence induction with thiopentone 5-7mgkg~'
and suxamethonium lmgkg1. The trachea was
intubated and the patient's lungs ventilated with
67 % nitrous oxide and 0.5-2 % isoflurane in oxygen
as indicated clinically. Neuromuscular paralysis was
maintained with vecuronium 0.1 mg kg '. Morphine
0.1 mg kg 1 was given during operation. At the end
of surgery, residual neuromuscular block was
antagonized with neostigmine and glycopyrronium
in appropriate doses. In the recovery area, patients
were made comfortable by administration of incre¬
ments of morphine 50 pg kg-1 if required.
Before patients left the recovery area, the PCA
machine (Graseby PCAS or 3300) was connected.
The solution used consisted of morphine sulphate
1 mg kg1 diluted to 50 ml with 0.9% saline to give
a concentration of 20 pg kg-1 ml h The PCA ma¬
chine was attached to the side arm of a Cardiff one¬
way valve incorporated into the i.v. infusion cannula.
The settings used were a bolus dose of 1 ml
(20 pg kg ') with a lockout interval of 5 min. Patients
were allocated randomly (by means of a computer-
generated list) to receive either this PCA regimen or
the same PCA regimen with a background infusion
of morphine 1 ml h 1 (20 pg kg 1 h-1).
After operation, patients breathed air and a moni¬
toring regimen described previously [10] was used:
ApQj, ventilatory frequency, sedation score, pain
score and nausea score, the number of demands
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made and the volume of solution infused were
recorded hourly. Patients were visited three times
daily by one of the authors, when the correct use of
the trigger was emphasized and syringes were
replaced if necessary. A named anaesthetist was
available to deal with any problems relating to the
PCA regimens. The PCA was discontinued when
there was a consistent decline in use and patients
were able to take oral analgesics.
Pain was scored using a four-point self-reporting
score which has been validated previously [11]: A =
asleep; 0 = no pain; 1 = not really sore; 2 = quite
sore; 3 = very sore. Children were not awakened for
assessment unless the nurse suspected oversedation;
"A" was recorded on the chart at these times.
Sedation was scored using a four-point scale: 0 =
eyes open spontaneously; 1 = eyes open to speech;
2 = eyes open when shaken; 3 = unrousable.
Nausea was scored on a four-point scale: 0 =
none; 1 = nausea only; 2 = vomited once in the past
1 h; 3 = vomited more than once in the past 1 h.
If there was a pain score of 3, a sedation score of
3 or a nausea sore of 3, the named anaesthetist was
asked to see the patient.
Results were analysed using theMann-Whitney U
test and chi-square tests as appropriate.
RESULTS
Details of the patients are shown in table I.
The total morphine consumption in the PCA +
background group was significantly (P < 0.01)
Table I. Patient characteristics and details of morphine usage
(number, mean (range or SD)). * P < 0.05 between groups
PCA +
PCA only background
Sex (M: F) 11:9 12:8
Age (yr) 9.6 (6-12) 10.2 (6-12)




Duration of PCA (h) 36.9 (11.1) 37.1 (7.4)
Morphine usage
(pg kg% 980 (434) ★ 1635 (748)
(pg kg"1 h"1) 27.6 (12.7) ★ 43.3 (14.8)
Background infusion
(pg kg-1) 694(189)
PCA (pg kg-') 980 (434) 941 (718)
Duration of PCA (h)
Fig. 1. Mean (sd) 4-hourly total pain scores in patients receiving
PCA only (□) or PCA + background infusion (#).
greater than that in the PCA only group. There was
no significant difference in the amounts of morphine
self-administered in the two groups.
For each patient, the hourly pain scores during
each 4-h period were summed at 4-h intervals after
the start of treatment and the means for patients in
the two groups calculated (fig. 1).
There were no significant differences between the
scores of the two groups in any of these periods.
There were significantly more instances of 5p0,
less than 94% in the PCA+ background group (143)
than in the PCA only group (94) (P < 0.001). The
smallest values of SpQt recorded at any time
(including those noted between hourly recordings)
in the two groups were in the ranges 83-95 % (mean
91 %) in the PCA + background group and 88-94%
(mean 92%) in the PCA only group.
Four occasions when ventilatory frequency was
< 10 b.p.m. were noted in the same patient who was
receiving a background infusion. Sp02 values at these
times were 96%, 93%, 97 % and 90%, respectively.
The slowest ventilatory frequencies recorded in the
two groups were 7-18 b.p.m. (mean 16 b.p.m.) in the
PCA + background group and 12-20 b.p.m. (mean
17 b.p.m.) in the PCA only group.
The occurrence of sedation scores of 2 or greater
were compared. There were no recordings of 3 in
either group, but a significantly greater number of
scores of 2 in the PCA + background infusion group
(13) than in the PCA only group (4) (P < 0.05).
There was a significantly greater incidence of
nausea and vomiting in the PCA + background group
(37) than in the PCA only group (15) (P < 0.01).
Antiemetics were given to one child in the PCA +
background group.
The number of adverse events (.Sp02<94%,
sedation scores 2, nausea and vomiting) during the
first 24 h of PCA use and subsequently did not differ
between the groups.
The amount of time that patients in the two
groups spent asleep was compared separately for the
periods from 22:00 to 06:00 (night) and from 06:00
to 22:00 (day). Patients in the PCA + background
group spent significantly (P < 0.001) more time
asleep at night (198 h) than those in the PCA only
group (154 h). There was no difference between the
two groups in the time spent asleep during the day.
Similar numbers of patients in both groups were
operated on during the day and at night. The effect
of the timing of operation on sleep pattern should,
therefore, have been the same in both groups.
The analgesia provided in both groups was
generally very good, with only 119 scores of 2 =
quite sore or 3 = very sore from a total of 1521
scores (59 of 759 scores in the PCA only group and
60 of 762 in the PCA + background infusion group).
One child in the PCA + background group had the
background infusion discontinued because of per¬
sistently decreased Sp0 when asleep, although the
ventilation frequency was always 14 b.p.m. or
greater.
DISCUSSION
Since its first use in children in 1987, PCA has
become a widely used and effective treatment for
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acute pain in selected children as young as 5 yr. Most
reports of its use in children are, however, simply
descriptive and there are few controlled studies
which compare different regimens in terms of
efficacy, dosage and adverse effects.
The use of a concurrent background infusion with
PCA in adults is currently an area of debate in the
literature. It has been shown to improve pain relief
in two studies [12, 13]. In one of these [12], the use
of a background infusion after abdominal hyster¬
ectomy not only improved analgesia but was associ¬
ated with improved sleep patterns and increased
patient satisfaction without an increase in opioid-
induced side effects. The other study [13] found that
the use of a background infusion improved analgesia
but was associated with an increase in opioid-related
side effects such as nausea and vomiting. Significant
respiratory depression was not observed.
Other studies have shown no benefit when a
background infusion was added to the PCA regimen
[14—16]. In these patients, morphine consumption
was increased with no improvement in analgesia.
The incidence of side effects was not increased and
respiratory depression was not noted in the group
receiving a background infusion.
In paediatric practice, one study [17] has com¬
pared PCA with and without a background infusion
(in a comparison with i.m. injections). In that study,
the infusion used was morphine 15 jig kg-1 h-1.
The PCA only group received bolus doses of
25pgkg_1 and the PCA + background infusion
group received bolus doses of morphine 18 gg kg-1.
In both groups, lockout time was 10 min. There
were no differences in morphine consumption,
sedation, nausea or vomiting between the groups.
Respiratory depression was not noted in any patient.
The PCA + background group was found to have
smaller pain scores than the PCA only group. This
study used patient and nursing visual analogue
scores for pain assessment, whereas our study used a
patient self-report scale; this may account for the
different findings of the two studies. Another study
[18] in children found that PCA + background
infusion did not improve analgesia, but was as¬
sociated with a better sleep pattern than PCA alone,
with no increase in the incidence of side effects.
Our study has found that the use of a background
infusion of morphine 20ggkg~'Ir1 in a PCA
regimen for children undergoing lower abdominal
surgery produced a significant increase in morphine
consumption without improving pain relief, and a
significant increase in the incidence of side effects
(respiratory depression, over-sedation and nausea or
vomiting). Patients in the PCA + background group
spent more time asleep at night than those in the
PCA only group. There was no suggestion that the
incidence of side effects increased with the duration
of PCA use as the severity of postoperative pain
declined.
The great variability in the morphine require¬
ments of our patients, who had all undergone the
same operation, is shown by the large standard
deviation in the amount of morphine self-admin¬
istered. The use of a fixed dose ofmorphine to cope
with this wide variability would be expected to be
unsuccessful. This may be why the use of a relatively
small fixed infusion in addition to the PCA produced
no discernible improvement in analgesia.
This is the first study to have shown an increased
incidence of respiratory depression in patients re¬
ceiving a background infusion compared with those
receiving PCA only. Respiratory depression has
been considered to be one risk associated with the
addition of an infusion to PCA, but has not
previously been shown to occur. The reason for this
is probably that the previous studies comparing PCA
with and without a background infusion [12-17] and
the descriptive publications of patients receiving
PCA + background have relied on intermittent
timing of ventilatory frequency as an indicator of
respiratory depression. This has been shown to be a
late and insensitivemonitor of respiratory depression
[19,20]. Arterial oxygen saturation (Sa0;) while
breathing air is a more sensitive monitor of adequate
ventilation and it has been suggested that pulse
oximetry should be routine for the monitoring of
children receiving PCA [21]. An Sa02 of 94%
corresponds to a PaGi of 10 kPa in healthy patients
and indicates mild hypoxia and reduced reserve
should further respiratory depression occur.
The use of PCA in adults also is associated with an
incidence of respiratory depression. This may occur
in up to 40% of patients breathing air after upper
abdominal surgery [22]. Patients using PCA after
lower abdominal surgery have been shown to be
more likely to suffer episodes of mild hypoxaemia
than patients receiving i.m. or extradural morphine
[23], Other studies have shown no difference be¬
tween the incidences of hypoxaemia in adults
receiving PCA and those receiving i.m. morphine
[22],
In our study, 15% of Spo values were less than
94% in the PCA only group. The significance of this
is unclear as there is no information on the incidence
of hypoxaemia detected by pulse oximetry in chil¬
dren breathing air and given i.m. opioids.
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PATIENT-CONTROLLED ANALGESIA WITH LOW DOSE
BACKGROUND INFUSIONS AFTER LOWER ABDOMINAL
SURGERY IN CHILDREN
E. DOYLE, I. HARPER AND N. S. MORTON
SUMMARY
Forty-five children (aged 6-12 yr) undergoing
appendicectomy received one of three analgesic
regimens using patient-controlled analgesia (PCA)
with morphine: no background infusion (BO);
background infusion 4 pg kg1 h~1 (B4); back¬
ground infusion lOggkg1 h1 (BIO). Total con¬
sumption of morphine was greater in group BIO
compared with groups BO (P < 0.01) and B4 (P <
0.05). There was no significant difference in
morphine consumption in groups BO and B4. All
three groups self-administered similar amounts of
morphine and there were no significant differences
in pain scores or incidence of excessive sedation.
Group B4 suffered less hypoxaemia compared with
groups BO (P < 0.01) and BIO (P <0.001). Group
BIO suffered more nausea and vomiting than
groups BO (P < 0.001) and B4 (P < 0.001), but
there was no significant difference in the incidence
of nausea and vomiting between groups BO and B4.
Groups B4 and BIO spent more time at night asleep
than group BO (P < 0.05). There were no significant
differences between the groups in the amount of
time spent asleep during the day. Inclusion of a
background infusion ofmorphine 4 pg kg~' h~' in a
PCA regimen for children did not increase the
incidence of side effects and was associated with
less hypoxaemia and a better sleep pattern than no
background infusion. (Br. J. Anaesth. 1993; 71:
818-822)
KEY WORDS
Analgesia: patient-controlled. Vomiting, nausea.
Patient-controlled analgesia (PCA) is now used in
children as young as 5 yr for the treatment of
postoperative pain [1], The drug used most com¬
monly is morphine, in a bolus dose of 10-25 pg kg-1
and a lockout interval of 5-15 min. These settings
are empirical and there are few well conducted
studies which have compared different PCA regi¬
mens in paediatric practice. In particular, the
benefits and risks of background infusions have not
been defined. Adult studies give conflicting results
[2-6] and one study in children [7] found an
improvement in analgesia without an increase in side
effects with a background infusion of morphine
15pgkg-1h_1. A more recent paediatric study [8]
found that a background infusion of morphine
20 pg kg-1 h 1 did not improve pain scores, but was
associated with a better sleep pattern. However, the
background infusion was associated with a greater
incidence of hypoxaemia, excessive sedation, nausea
and vomiting compared with the PCA-only regimen.
This study was carried out to assess the effect of
two different low-dose background infusions on
postoperative analgesia, sleep pattern, morphine
consumption, sedation, nausea, vomiting, respir¬
atory depression and arterial oxygen saturation in air
(Spo,)-
PATIENTS AND METHODS
The study was approved by the hospital Ethics
Committee and written informed parental consent
was obtained. On the basis of previous work using
this methodology [8], it was calculated that this
study had a 90 % probability of detecting differences
between groups which would be significant at the
5% level. Forty-five children aged 6-12 yr under¬
going appendicectomy were recruited. Patients were
visited before operation, when the principles of
using PCA were explained to the child and parents.
Patients were taught to use the trigger of the PCA
machine during this visit. Patients were not studied
if they had received preoperative analgesia.
All patients received a standard general anaesthetic
which comprised rapid sequence induction with
thiopentone 5-7 mg kg 1 and suxamethonium
1 mg kg-1. The trachea was intubated and the
patient's lungs ventilated with 67 % nitrous oxide
and 0.5-2.0% isoflurane in oxygen as indicated
clinically. Neuromuscular block was maintained with
vecuronium 0.1 mg kg-1. Morphine 0.1 mg kg^1 was
given during operation. At the end of surgery,
neuromuscular block was antagonized with neo¬
stigmine and glycopyrronium in appropriate doses.
In the recovery area, patients were made comfortable
with boluses of morphine 50 pg kg-1 if required.
Before the patient left the recovery area, the PCA
pump was set up (Graseby PCAS and Graseby
3300). The solution consisted of morphine 1 mg kg~'
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Table I. Patient characteristics and details ofmorphine consumption (mean (range or SD)). Significant differences compared
with group B10\ *P < 0.05; **P < 0.01












































diluted to 50 ml with 0.9 % saline (20 pg kg"1 mP1).
The PCA machine was attached to the side arm of a
Cardiff one-way valve incorporated into the i.v.
infusion cannula. Patients were allocated randomly
(computer-generated list) to receive one of three
different PCA regimens: group B0 received bolus
doses ofmorphine 20 pg kg-1 with a lockout interval
of 5 min and no background infusion; group B4
received bolus doses of 20 pg kg-1 with a lockout
interval of 5 min and a background infusion of
morphine 4pgkg1h1; group B10 received bolus
doses of 20 pg kg"1 with a lockout interval of 5 min
and a background infusion of 10 pg kg"1 h_1.
After operation, patients breathed air and a
monitoring regimen described previously [9] was
used. This involved a high dependency level of
nursing care with hourly recordings of Sp0z, ventil¬
atory frequency and sedation, pain and nausea scores.
The number of demands made and the volume of
solution infused were also recorded hourly. Patients
were reviewed regularly by one of the authors. There
was always a named anaesthetist available to deal
with any problems relating to the PCA regimen.
PCA was discontinued when there was a consistent
decline in use and the patient was able to take oral
analgesics.
Pain was measured using a four-point, self-
reporting score which has been validated previously
[10]: 0 = no pain; 1 = not really sore; 2 = quite
sore; 3 = very sore.
Children were not awakened from sleep for
assessment unless the nurse suspected excessive
sedation and "A" was recorded on the chart at these
times. Sedation was scored using a four-point scale:
0 = eyes open spontaneously; 1 = eyes open to
speech; 2 = eyes open when shaken; 3 = unrousable.
We considered patients to be sedated excessively
if they were not rousable by speech and required to
be shaken. Experienced paediatric nurses were able
to differentiate between a child who was asleep
naturally and one who was sedated excessively as a
result of opioid.
Nausea was scored on a four-point scale: 0 =
none; 1 = nausea only; 2 = vomited once in the past
1 h; 3 = vomited more than once in the past 1 h.
If there was a pain score of 3, a sedation score of
3 or a nausea score of 3, the named anaesthetist was
asked to see the patient.
Results were analysed using analysis of variance
and the Mann-Whitney U test for pain scores and
morphine consumption, and chi-square tests for
comparisons of events between groups.
RESULTS
Patient characteristics are shown in table I.
Two patients in group B0, one in group B4 and
one in group B10 received a bolus of morphine
50 pg kg-1 in the recovery area. These boluses were
not included in the figures for postoperative con¬
sumption of morphine.
Patients in all three groups self-administered
similar amounts of morphine using the PCA ma¬
chine. Total morphine consumption was signi¬
ficantly greater in group B10 compared with groups
B0 (P < 0.01) and B4 (P < 0.05). Group B4 self-
administered 2 pg kg"1 h_1 less than group B0; thus
when the background infusion is taken into account,
group B4 received 2 pg kg-1 h_1 more morphine than
group B0.
For each patient, the hourly pain scores during
each 4-h period after the start of the PCA regimen
were totalled. The mean 4-hourly totals for patients
in the three groups are shown in figure 1. There were
no significant differences between the scores of the
three groups during any of these periods.
Table II shows the numbers of patients in each
group who were receiving PCA at the end of each
12-h period after operation.
readings were accepted as valid and recorded
only if they were consistent over 2-3 min and there
was a good pulse signal on the oximeter screen. The
occurrence of hypoxaemic episodes (defined as 5p0j
<94%) in the three groups is shown in table III.
Group B10 had significantly more recordings less
than 94% compared with groups B0 (P < 0.001) and
B4 (P < 0.001). Group B0 had significantly more
recordings less than 94% compared with group B4
(P < 0.01). The smallest Sp0i values in the three
groups were 86—95% (mean 91.6%) in group B0,
86-95% (mean 92.4%) in group B4 and 86-95%
(mean 90.3%) in group B10.
The slowest ventilatory frequencies recorded in
the three groups were 12-18 b.p.m. in group B0,
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Fig. 1. Mean (sd) 4-hourly total pain
table ii. Numbers of patients in each group using PCA after each
12-h interval after operation
Group Group Group
BO B4 B10
12 h 15 15 15
24 h 15 15 15
36 h 13 13 14
48 h 2 4 3
Table III. Comparison of incidence of sp0^ readings less than 94°/0
in the three groups. **Significantly greater than group B4 (P < 0.01,
X2=6.9); ***significantly greater than BO and B4 (P <0.001,
X2=51)
Group B0 Group B4 Group B10
SPo2<94% 78** 56 159***
SPo2>94% 499 583 523
Table IV. Comparison of the incidence of emetic sequelae in the three
groups. ***Significant difference (P < 0.001) compared with groups
BO (x2= 16.2) and B4 (x2 = 14-9)
Group Group Group
B0 B4 B10
Episodes of emetic 20 22 60***
sequelae
No. of patients who 8 8 10
complained of emetic
sequelae
Table V. Comparison of duration of sleep between 22:00 and 06 :00
{night) and between 06:00 and 22:00 {day) in the three groups.
*Significant difference (P < 0.05) compared with groups B4 {x2 =
5.3) and BIO (x' = 5.3)
Group BO Group B4 Group BIO
Night
Asleep 142* 178 217
Awake 78 61 68
Day
Asleep 85 92 86
Awake 272 308 311
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of PCA (h)
s in groups BO (■), B4 {0) and BIO (□).
A sedation score of 3 was not recorded in any
patient. A sedation score of 2 occurred on 22
occasions in group BO, 19 in group B4 and on 21
occasions in group BIO (not significant).
Group BIO suffered significantly more emetic
sequelae than groups BO (P < 0.001) and B4 (P <
0.001) (table IV). There was no significant difference
in the incidence of emetic sequelae between groups
B0 and B4. Antiemetics were given to one patient in
group B10.
The amount of time spent asleep was compared in
the three groups by analysing the periods from 22:00
(after the evening ward drug round) to 06:00 (night)
and from 06:00 to 22:00 (day) separately. Groups B4
and B10 spent significantly more time asleep at night
compared with patients in group B0 (P < 0.05).
There was no significant difference between groups
B4 and B10 in the amount of time spent asleep at
night, and no significant differences between the
groups in the amount of time spent asleep during the
day (table V). Similar numbers of patients in all
groups were operated upon during the day and at
night.
Three patients in group B10 had the background
infusion discontinued because of persistent excessive
sedation.
DISCUSSION
There are few controlled studies which have com¬
pared different PCA regimens for children in terms
of efficacy, dosage and adverse effects. The role for a
background infusion with PCA has not been defined
clearly. The perceived advantage of using a back¬
ground infusion is that it improves continuity of
analgesia and provides analgesia during sleep. This
may improve sleep patterns in postoperative patients
by reducing the number of occasions when patients
are wakened by pain which requires subsequent use
of the PCA device for relief.
The operation of appendicectomy provides a good
model for the study of postoperative analgesic
regimens. It involves a standard surgical procedure
and a degree of peritoneal irritation which ensures
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that postoperative morphine requirements when
self-administered with a PCA machine are of the
order of 20-30 jig kg-1 h"1, which is the same as that
in children after more major abdominal and or¬
thopaedic surgery [11-14].
This study has shown that the use of a background
infusion ofmorphine 4 pg kg-1 h_1 in a PCA regimen
for children after lower abdominal surgery caused no
increase in side effects compared with no background
infusion and was associated with less hypoxaemia
and a better sleep pattern than PCA only. A
background infusion of morphine 10 pg kg-1 h"1 was
associated with a better sleep pattern also, but was
accompanied by a significant increase in the in¬
cidence of hypoxaemia and nausea and vomiting.
Unlike a background infusion of 20 pg kg-1 h"1 [8],
these smaller infusion rates were not associated with
an increase in the incidence of excess sedation.
The reason why a background infusion of mor¬
phine 4 pg kg-1 It1 produces less hypoxaemia than a
PCA regimen with no background infusion may be
that the infusion produced better analgesia and
improved ventilation. This suggests that the method
for assessing pain used in this study (patient self-
report) is relatively insensitive. A specific assessment
of pain on moving or coughing may have revealed
differences in analgesia between groups BO, B4 and
BIO. We have also previously noted that periods of
hypoxaemia often correspond with high pain scores
[9]-
In adult studies, the use of a background infusion
has been shown to improve pain relief in two studies
[2,3], but not in others [4-6]. The studies which
found no benefit from a background infusion did not
assess pain during movement. In contrast, one of the
studies which did find improved analgesia with a
background infusion [3] did assess pain on move¬
ment. The other study [2] did not make clear if pain
was assessed only at rest or during movement. Two
studies [3, 5] found an increase in opioid-induced
side effects (other than respiratory depression) with
a background infusion. The size of background
infusion of morphine varied from 0.6 mg h"1 to
1.5 mgh 1 (pethidine lOmglr1 in one), which is
equivalent to 10-20 |tg kg"1 h"1.
In paediatric practice, two studies [7,8] have
compared PCA with and without a background
infusion. In one [7] the infusion used was morphine
15 jig kg"1 h"1 and there were no differences in
morphine consumption, sedation, nausea or vomi¬
ting. Respiratory depression (as measured by venti¬
latory frequency) was not noted in any patient. The
PCA plus background infusion group were found to
have smaller pain scores than the PCA only group as
assessed by patient and nurse visual analogue scales.
In the other study [8], a background infusion of
morphine 20 gg kg"1 hr1 produced a significant in¬
crease in morphine consumption without improving
pain scores (assessed by patient self-report). There
was also a significant increase in the incidence of
opioid-induced side effects (respiratory depression,
excessive sedation, nausea and vomiting) in the
background infusion group. However, the use of a
background infusion was associated with a better
sleep pattern.
Opioid-induced respiratory depression has been
considered to be a risk of background infusion, but
has been shown to occur only in one paediatric study
[8] when Sp0, was measured continuously with
patients breathing air. Intermittent recording of
ventilatory frequency has been shown to be an
insensitive monitor of opioid-induced respiratory
depression in adults [15-17]. Studies which have
relied on intermittent recording of ventilator fre¬
quency as an indicator of respiratory depression and
have concluded that a background infusion does not
produce respiratory depression [2—7] may be falsely
optimistic. Arterial oxygen saturation while breath¬
ing air is a more sensitive monitor of adequate
ventilation. Sp0o 94% corresponds to an arterial
oxygen tension of 10 kPa and indicates mild hypox¬
aemia. In the absence of other causes of hypoxaemia,
this indicates a degree of ventilatory depression
which may be caused by opioid administration or
pain. In our experience, pain is a more common
reason for hypoxaemia than opioid overdosage. This
emphasizes the need for careful and repeated assess¬
ments by experienced staff.
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Comparison of different bolus doses of morphine for patient-
controlled analgesia in children
E. Doyle, K. J. Mottart, C. Marshall and N. S. Morton
SUMMARY
Forty children undergoing appendicectomy were
allocated randomly to receive one of two PCA
regimens with morphine. Group B10 received bolus
doses of 10 pg kg'1 and group B20 received bolus
doses of 20 pg kg1, in both groups there was a
lockout interval of 5 min and a background infusion
of 4 pg kg'1 Group B20 self-administered con¬
siderably more morphine (P < 0.01) than group
B10. There was no difference between the pain
scores of the groups at rest. Group B20 had
significantly (P < 0.05) smaller pain scores during
movement than group BIO and the latter group
suffered significantly (P < 0.01) more hypoxaemic
episodes than group B20. There were no differences
between the groups in the incidence of vomiting,
excess sedation or the amount of time spent asleep
at night. (Br. J. Anaesth. 1994; 72: 160-163)
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Patient-controlled analgesia (PCA) is now used
commonly for the treatment of acute pain in selected
children [1], Regimens described have used bolus
doses of morphine ranging from 10 to 50 (tg kg 1
[2-6], but there have been no comparative studies of
different bolus doses in children in terms of efficacy
and side effects.
This study was carried out to compare bolus doses
of 10 pg kg 1 and 20 pg kg 1 in a PCA regimen for
children, in terms of efficacy, morphine consumption
and side effects. The PCA regimen used included a
background infusion of 4 pg kg ' h"1, which has
been shown to be superior to a PCA regimen without
a background infusion in children [7].
A pain scoring system which assesses pain only at
rest does not discriminate well between different
analgesic regimens [7], This study was designed to
include an assessment of pain both during movement
and at rest, to improve sensitivity.
PATIENTS AND METHODS
The study was approved by the hospital Ethics
Committee and written informed parental consent
was obtained for all patients. We studied 40 children
aged 6-14 yr undergoing appendicectomy. Opera¬
tions were performed as urgent procedures in the
first available operating theatre when the patient had
been adequately hydrated. Patients were visited
before operation when the principles of using PCA
were explained to the child and parents. Patients
were taught to use the trigger of the PCA machine
during this visit. Preoperative analgesia was pre¬
scribed by surgical staff on clinical grounds without
reference to this study. Patients were not recruited if
analgesia had been prescribed at the time of the
preoperative visit.
All patients received a standard general anaesthetic
(with no premedication) which consisted of a rapid
sequence induction with thiopentone 5-7 mg kg-1
and suxamethonium lmgkg"1. The trachea was
intubated and the patient's lungs ventilated with
67 % nitrous oxide and 0.5-2.0 % isoflurane in
oxygen. Neuromuscular block was maintained with
vecuronium 0.1 mg kg-1. Morphine 0.1 mg kg 1 was
given during operation. At the end of surgery
neuromuscular block was antagonized with neo¬
stigmine 50 pg kg 1 and glycopyrronium 10 pg kg"1.
In the recovery area, the patient was titrated to
comfort with boluses of morphine 50 pg kg-1 if
required.
Before the patient left the recovery area, the PCA
pump (Graseby PCAS) was set up. The solution
used consisted of morphine 1 mg kg-1 diluted to
50 ml with 0.9% saline to give a concentration of
20 pg kg-1 ml"1. The PCA machine was attached to
the side arm of a Cardiff one-way valve incorporated
into the i.v. infusion system. Patients were allocated
randomly (by means of a computer-generated list) to
receive one of two different PCA regimens: group
B10 received bolus doses of morphine lOpgkg"1
with a lockout interval of 5 min and a background
infusion of 4 pg kg 1 h"1; group B20 received bolus
doses ofmorphine 20 pg kg"1 with a lockout interval
of 5 min and a background infusion of 4 pg kg"1 h"1.
After operation the patient breathed air. A moni¬
toring procedure described previously [8] was used,
involving a high-dependency level of nursing care
with hourly recordings of Sp0„, ventilatory fre¬
quency, sedation score, pain score and nausea score.
The number of demands made and the volume of
solution infused were also recorded hourly. Patients
were reviewed three times a day by one of the
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authors. There was always a named anaesthetist
available to deal with any problems relating to the
PCA regimens. PCA was discontinued when there
was a consistent decline in use and the patient was
able to take oral analgesics.
Pain was scored both at rest and during a specified
movement, by observers who were unaware of the
patient's treatment group. Pain at rest was scored
using a four-point, self-reporting score which has
been validated previously [9] as follows: 0 = no
pain; 1 = not really sore; 2 = quite sore; 3 = very
sore.
Pain on movement was scored using the same
scoring system during a vital capacity breath fol¬
lowed by a cough. Children were not awakened from
sleep for assessment unless the nurse suspected
oversedation; "A" was recorded on the chart at
these times. Sedation was scored using a four-point
scale: 0 = eyes open spontaneously; 1 = eyes open to
speech; 2 = eyes open when shaken; 3 = unrousable.
Nausea was scored on a four-point scale: 0 =
none; 1 = nausea only; 2 = vomited once in the past
1 h; 3 = vomited more than once in the past 1 h.
If there was a pain score of 3, a sedation score of
3 or a nausea score of 3, the named anaesthetist was
asked to attend the patient.
Results were analysed using the Mann-Whitney
U test for pain scores and morphine consumption
and chi-square tests for comparisons of events
between groups.
RESULTS
The two groups were similar in age, weight, sex
distribution, duration of PCA use and timing of
surgery (table I). Patients in group B20 self-
administered significantly more morphine than those
in group BIO (P < 0.01). There was no significant
difference between the groups in the percentage of
unsuccessful demands for analgesia (those which
were made during the lockout period). Table II
shows the number of patients in each group who
were still using PCA at the end of each 12-h period
after operation.
Pain scores were compared by calculating the
mean hourly pain score during each 4-h period after
operation and comparing the groups during each of
these periods. There were no significant differences
between the groups at rest at any time except for the
period 16-20 h after operation, when the difference
just reached significance at the 5 % level (fig. 1). Pain
scores during movement in group B20 were sig¬
nificantly (P < 0.05) smaller than those in group B10
during each 4-h period, except for that between 44
and 48 h after operation (fig. 2). At 44-48 h after
operation no patient in group B20 complained of
pain at rest, although some did have pain on
movement.
There were significantly more Sp02 recordings less
than 94% in group B10 than in group B20 (P
< 0.01) (table III). Readings were regarded as valid
Table I. Patient data and details of morphine consumption (mean
{range or SD)). **P < 0.01 between groups
Group B10 Group B20
Sex (M: F) 12:8 10:10
Age (months) 128 (95-150) 123 (93-151)




Duration of PCA use (h) 43 (7.8) 41 (6.6)
Morphine consumption
(pg kg"1) 505 (224) ** 1124 (691)
(pg kg-1 h-1) 16 (5.8) ** 30.4 (14.0)
Self-admin, by PCA 12 (5.8) ** 26.4 (14.0)
(pg kg-1 h"1)
Successful demands (%) 71 (17) 76.6 (16.4)
Table II. Numbers of patients in groups B10 and B20 using PCA
at the end of each 12-h period after operation
No. using PCA
Time after op. Group B10 Group B20
12 h 20 20
24 h 20 20
36 h 17 19
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Fig. 1. Mean (sd) hourly pain scores at rest in patients in groups B10 (■) and B20 (□). * P < 0.05 between groups.






*** * **** * * *
0 4 8 12 16 20 24 28 32 36 40 44 48
Duration of PCA (h)
Fig. 2. Mean (sd) hourly pain scores on movement in groups BIO (■) and B20 (□). * P < 0.05 between groups.
Table III. Comparison of the incidence (absolute numbers of
episodes) of Spg2 recordings of less than 94 % in groups B10 and B20.
X2= 8.1; P <0.01
Group B10 Group B20
SPo, <94% 92 61
SPo2»94% 738 798
Table IV. Comparison of absolute number of occasions after
operation on which patients in groups B10 and B20 vomited and the
amount of time spent asleep between 22:00 and 06:00 {night) and
between 06:00 and 22:00 (day). No significant differences between
groups
Group B10 Group B20
Episodes of vomiting (No.) 6 3
Sleep at night (h)
Asleep 207 200
Awake 140 134
Sleep during day (h)
Asleep 95 89
Awake 417 407
and recorded only if they persisted for 5 min, if there
was a good pulse signal on the oximeter screen and
artefact caused by poor positioning or venous
engorgement had been excluded.
There was no significant difference in the in¬
cidence of vomiting in the two groups after operation
(table IV).
The amount of time that patients spent asleep was
assessed by comparing the periods from 22:00 to
06:00 (night) and from 06:00 to 22:00 (day) sep¬
arately. There was no significant difference between
the groups in these periods (table IV).
There were no episodes of oversedation in any
patient in each group.
DISCUSSION
The optimal bolus dose for use with PCA has been
defined as the minimum dose which produces
adequate analgesia consistently without causing
subjective or objective side effects [10]. An in¬
adequate bolus dose tends to result in inadequate
analgesia, while too large a bolus may cause excessive
side effects. Ideally, the patient should not be
required to make too frequent demands in order to
attain adequate analgesia.
This study has shown that a bolus dose of
morphine 10 pg kg'1 was associated with greater
pain scores and more hypoxic episodes than a bolus
dose of 20 pg kg'1. There was no difference between
the groups in the incidence of other opioid-induced
side effects, sleep pattern or the percentage of
unsuccessful demands for analgesia.
These findings are in agreement with those in
adult studies in which inadequate bolus doses were
associated with increased pain scores [10,11], In
those studies patients did not use the PCA device to
achieve satisfactory analgesia, despite the fact that
there was the facility to self-administer more an¬
algesic. This suggests that patients do not usually
use PCA to titrate analgesic drugs to a minimum
effective analgesic concentration. The time since the
previous analgesic demand and the expected benefit
from a demand, in terms of analgesia, appear to be
important factors in the frequency of patient
demands [12]. If patients do not use PCA in response
to pain and are prepared to suffer pain on occasion
rather than use the PCA pump, studies in which the
efficacy of alternative analgesic regimens is assessed
by means of the morphine-sparing effect as judged
by self-administered PCA morphine consumption
may be unreliable.
Many of the decreased Sp0., readings noted were
associated with greater pain scores and the finding of
an increased incidence of decreased SpQt in group
B10 is presumably caused by inadequate ventilation
as a consequence of pain leading to restriction of
abdominal movement. This association of hypox-
aemia with increased pain scores has been noted
previously [8]. An .Sp02 reading of 94 % corresponds
with an arterial oxygen tension of about 10 kPa and,
in otherwise healthy patients breathing air, indicates
a mild degree of ventilatory depression. This may be
caused by pain leading to inhibition of ventilatory
movement or by a relative overdosage of opioid.
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There were no differences between the groups in
pain scores at rest, although pain scores on move¬
ment were significantly different. This supports the
suggestion that, in studies of analgesic regimens,
pain scores at rest are not sufficiently sensitive to
discriminate between regimens and such studies
should include an assessment of pain on movement
[7]-
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Comparison of i.v. and s.c. diamorphine infusions for the treatment
of acute pain in children
D. Semple, L. A. Aldridge and E. Doyle
Summary
We have compared the i.v. and s.c. routes of
administration for diamorphine infusions in children
undergoing abdominal surgery. Subjects received
general anaesthesia with extradural block and
diamorphine up to 20 pg kg 1 h"1 after operation.
There were no differences between the groups in
diamorphine consumption, pain scores or incidence
of side effects. The s.c. route appeared to be as
effective and safe as the i.v. route for administration
of diamorphine infusions in children undergoing
elective surgery. (Br. J. Anaesth. 1996; 76:
310-312)
Key words
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The use of i.v. opioid infusions to treat postoperative
pain in children is a common and effective analgesic
technique [1], It requires a dedicated i.v. cannula for
opioid administration in addition to one for i.v. fluids
and drugs. Alternatively, the same cannula may be
used for both fluids and opioid administration if an
antireflux valve is used. The option of a second i.v.
cannula is not always available, particulary in infants,
while antireflux valves are expensive and make the
infusion site bulky and difficult to nurse.
An alternative route of administration for opioid
infusions which does not have these disadvantages is
the s.c. route. This is used extensively in terminal
and chronic pain and has also been described for the
management of acute pain in adults [2], The efficacy
of s.c. infusions in children has been demonstrated
recently [3]. For this technique to become wide¬
spread and accepted it must be shown to be as
effective as the i.v. route with the same or a lower
incidence of side effects. The i.v. and s.c. routes of
administration have not been compared in children.
This study was designed to compare these two routes
in children undergoing abdominal surgery. On the
basis of previous work using similar methodology [4]
the power calculated for the study was that it would
have a 90% chance of detecting differences between
the groups which were significant at the 5 % level.
Methods and results
The study was approved by the local Ethics
Committee and written informed parental consent
was obtained for each subject. We studied 30
children, aged 6 months to 11 yr, undergoing
abdominal surgery. Exclusion criteria included con¬
traindications to extradural block, significant hepatic
or renal impairment, and significant mental handicap
making assessment of pain difficult. Patients were
premedicated with EMLA cream and anaesthesia
was induced with propofol 3-4 mg kg-1 and atra-
curium 0.5 mg kg"1. After tracheal intubation, the
lungs were ventilated with 0.5-2% halothane and
70% nitrous oxide in oxygen. Patients were then
turned to the right lateral position and an extradural
catheter placed at an appropriate dermatomal level
for the proposed surgery. Extradural block was
provided with 0.25 % bupivacaine 1 ml kg-1 with
adrenaline 1/200000 (maximum 20 ml) in divided
doses. At the end of surgery, neuromuscular block
was antagonized and the trachea extubated.
Patients were allocated randomly to receive either
an i.v. or an s.c. infusion of diamorphine after
operation. In the i.v. group (group IV), a second 22-
gauge cannula was sited on the same side as the
cannula used for induction. In the s.c. group (group
SC), a 22-gauge cannula was sited s.c. over the
deltoid muscle on the same side as the i.v. cannula.
In group IV the solution used consisted of
diamorphine 1 mg kg-1 diluted in 50 ml of 0.9 %
saline to give a concentration of 20 pg kg"1 ml"1.
This was commenced at a rate of 1 ml h"1 (20 pg kg"1
h"1). In group SC the solution used consisted of
diamorphine 1 mg kg"1 diluted in 20 ml of 0.9%
saline to give a concentration of 50 pg kg"1 ml"1.
This was commenced at 0.4 ml h"1 (20 pg kg"1 h"1).
Diamorphine infusions were started in the recovery
area. Infusions were delivered using a Graseby
MS2000 pump.
After operation we used a monitoring regimen
described previously [5]. Patients breathed air and
had continuous monitoring of arterial oxygen satu¬
ration. We measured hourly values of ventilatory
frequency, pain score, sedation score, nausea score
and volume of diamorphine infused. Diamorphine
was infused at a maximum rate of 20 pg kg"1 h"1 and
boluses of diamorphine 50 pgkg"1 were available if
required.
Pain was assessed by a small group of experienced
paediatric surgical nurses and measured using a
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Figure 1 Comparison of pain scores (0 = 1, ■ = 2, □ = 3) in groups IV (A) and SC (B).
four-point scale described previously [6]: 1 = no
pain; 2 = mild pain; 3 = moderate pain; 4 = severe
pain. Children were not wakened from sleep for
assessments unless the nurse suspected excessive
sedation. Sedation was scored using a four-point
scale: 0 = eyes open spontaneously; 1 = eyes open in
response to speech; 2 = eyes open when shaken; 3 =
unrousable. Vomiting was scored on a three-point
scale: 0 = none; 1 = vomited once in the last hour; 2
= vomited more than once in the last hour.
Infusions were discontinued when there was a
consistent decline in diamorphine requirements and
patients were able to take oral analgesics. Results
were analysed using the Student's t test for para¬
metric data and the Mann-Whitney U test for non-
parametric data.
The two groups were similar in characteristics
(mean age 36 months in group IV and 33 months in
group SC), surgical procedures (eight gastrointes¬
tinal, two pyeloplasties, three nephrectomies and
two ureteric reimplantations in group IV and six
gastrointestinal, two pyeloplasties, five nephrec¬
tomies and two ureteric reimplantations in group
SC) and duration of surgery (median 80 min in
group IV and 65 min in group SC).
The duration of infusion analgesia (median 41 h in
group IV and 39 h in group SC) and total diamor¬
phine consumption (median 680 (range 220-1120)
|tg kg"1 in group IV and 600 (260-1160) |tg kg-1 in
group SC) did not differ significantly between the
groups. To assess efficacy, we compared the median
total pain scores in each group during each 4-h
period after operation. There were no significant
differences between the groups at any point (fig. 1).
Two children in group IV and three children in
group SC received one supplementary bolus of
diamorphine for inadequate analgesia at the maxi¬
mum infusion rate.
There were no significant differences between the
groups in the incidence of vomiting, excessive
sedation or hypoxic episodes. Five patients in group
IV and seven patients in group SC vomited.
Excessive sedation was defined as a sedation score of
2 or 3; a score of 2 occurred on two occasions in one
patient in group IV and on seven occasions in two
patients in group SC. All episodes of excessive
sedation occurred during the first postoperative day
while the infusion rate was 20 jtg kg-1 hr1. A
hypoxic episode was defined as Sp02 less than 94%;
there were 14 episodes in four patients in group IV
and 18 episodes in five patients in group SC.
Two cannulae in group IV and no cannulae in
group SC needed to be replaced during the diamor¬
phine infusion.
Comment
We have observed that the s.c. route of adminis¬
tration is as effective as the i.v. route for infusion of
diamorphine in children after elective surgery.
Although s.c. administration has been shown to
provide analgesia [3] in children, it has not been
shown previously to be as effective as the i.v. route.
The fact that equivalent analgesia can be provided
by this route with similar doses of diamorphine and
no increase in the incidence of side effects suggests
that this technique may be useful in children
receiving other opioids by infusion. Use of the s.c.
route for opioid infusions is likely to reduce the
practical difficulties associated with the provision of
this form of analgesia in small children. Intermittent
injections of opioid through an indwelling s.c.
cannula may be used instead of an infusion but, in
common with intermittent i.m. injections, may result
in periods of unrelieved pain alternating with
episodes of sedation or nausea induced by high
plasma concentrations of opioid after bolus dose
administration. There was no blinding of observers
to the type of infusion used in this study and there is
the possibility of bias in the recordings. Furthermore
the method of pain assessment used (observer
scoring) is not as satisfactory as patient self-report
and must be considered to be a relatively insensitive
discriminator between analgesic regimens.
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It should be noted that the subjects in this study
were elective normovolaemic patients. The s.c. route
would be contraindicated in patients with or at risk
of developing poor peripheral perfusion when there
would be a risk of accumulation of opioid at the
infusion site resulting in poor analgesia and sub¬
sequent absorption of this depot to give the equiva¬
lent of a large uncontrolled bolus of opioid.
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Comparison of patient-controlled analgesia in children by i.v. and
s.c. routes of administration
E. Doyle, N. S. Morton and L. R. McNicol
SUMMARY
Sixty children undergoing appendicectomy were
allocated randomly to receive one of two PCA
regimens with morphine. Group IV received stan¬
dard i.v. PCA with a bolus dose of morphine
20 pg kg~1 and a background infusion of
4 pg kg1 h~1 while group SC received PCA by the
s.c. route with a bolus dose ofmorphine 20 pg kg1
and a background infusion of 5 pg kg1 h In both
groups there was a lockout interval of 5 min. Group
SC self-administered significantly less morphine (P
< 0.05) and had a significantly (P < 0.01) greater
percentage of valid demands for analgesia than
group IV. There were no differences in pain scores
between the groups at rest or during movement.
Group IV suffered significantly (P < 0.01) more
hypoxic episodes than group SC. There were no
differences between groups in the incidence of
postoperative nausea and vomiting or oversed-
ation. S c. PCA appears to be as effective and safe
as i.v. PCA. By giving patients feedback on the
occurrence of valid demands for analgesia, s.c. PCA
may produce more appropriate and effective use of
PCA. (Br. J. Anaesth. 1994; 72: 533-536)
KEY WORDS
Analgesia: paediatric. Analgesia: patient-controlled.
Patient-controlled analgesia (PCA) is now used
commonly for the treatment of acute pain in selected
children [1-6]. All reported studies have used the i.v.
route of administration. The disadvantages of this
route include the need for a dedicated i.v. cannula
which may be a particular problem in children or
the need for a one-way anti-reflux valve in the i.v.
tubing, which is more expensive than a dedicated
cannula. In children, the use of an anti-reflux valve
makes the junction of the i.v. tubing and the cannula
bulky and awkward.
The s.c. route of administration is very satisfactory
for opioid infusions in acute [7-9] and chronic [10,
11] pain and also for bolus doses [12], If the s.c. route
of administration could be shown to be suitable for
PCA, this would offer potential advantages by
avoiding the need for either an anti-reflux valve or a
dedicated i.v. cannula. These advantages would be
particularly marked in children and in patients where
veins are at a premium, such as those with extensive
burns and those with chronic or terminal pain.
This study was performed to compare the s.c. and
i.v. routes of administration for PCA in children.
Both groups received a small background infusion
which has been shown to be superior to a PCA
regimen with no background infusion [13]. The
study included assessment of pain during movement
which has been shown to be a more sensitive
discriminator between analgesic regimens than
assessments carried out at rest [14].
PATIENTS AND METHODS
The study was approved by the hospital Ethics
Committee and written informed parental consent
was obtained for all patients. We studied 60 children
aged 6-14 yr undergoing appendicectomy. On the
basis of previous work using these methods [14], it
was calculated that the study had a 90% probability
of detecting differences in pain scores and side effects
which were significant at the 5 % level. Patients were
visited before operation when the principles of using
PCA were explained to the child and parents.
Patients were taught to use the trigger of the PCA
machine during this visit. Patients were not studied
if they had received analgesia before operation.
All patients received a standard general anaesthetic
which comprised a rapid sequence induction with
thiopentone 5-7 mg kg 1 and suxamethonium
lmgkg-1. The trachea was intubated and the
patients' lungs ventilated with 67% nitrous oxide
and 0.5-2.0% isoflurane in oxygen. Neuromuscular
block was maintained with vecuronium 0.1 mg kg-1.
Morphine 0.1 mg kg 1 was given during operation.
At the end of surgery, neuromuscular block was
antagonized with neostigmine and glycopyrronium
in appropriate doses. In the recovery area, patients
were titrated to comfort with bolus doses of mor¬
phine 50 pg kgif required.
Before patients left the recovery area, the PCA
pump was connected (Graseby, PCAS). Patients
were allocated randomly (by means of a computer
generated list) to receive one of two different PCA
regimens. One group received i.v. PCA (group IV)
and the other received PCA by the s.c. route (group
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Table I. Patient data and details of morphine consumption (mean (SD or range)). *P < 0.05, **P < 0.01
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SC). In group IV the solution used contained
morphine 1 mg kg"1 diluted to 50 ml with 0.9%
saline to give a concentration of 20 pg kg"1 ml"1. The
PCA syringe was attached to the side arm of a Cardiff
anti-reflux valve incorporated into the i.v. infusion
cannula. This group received bolus doses of
20 pg kg"1 (1 ml) with a lockout interval of 5 min and
a background infusion of 4 pg kg"1 h"1 (0.2 ml h_1).
In group SC, a 22-gauge catheter was sited s.c.
over the deltoid muscle of the same (non-dominant)
arm as the i.v. cannula. This cannula was flushed
with 1 ml of 0.9 % saline and secured with
Elastoplast tape. The PCA syringe was attached to
this cannula. In group SC the solution used
contained morphine 1 mg kg"1 diluted in 20 ml of
0.9 % saline to give a concentration of
50 pg kg"1 ml"1. This group received bolus doses of
20 pg kg1 (0.4 ml) with a lockout interval of 5 min
and a background infusion of 5 pg kg"1 h"1
(0.1 ml h"1). This background infusion differed from
that used in group IV because it was not possible to
give the same infusion with the dilution of morphine
used.
After operation patients breathed air. A moni¬
toring procedure described previously [15] was used.
This involved high dependency nursing care with
continuous pulse oximetry and hourly recordings of
ventilatory frequency and scores for sedation, pain
and nausea. The number of demands made, the
number of valid demands and the volume of solution
infused were also recorded hourly. Patients were
reviewed three times a day by one of the authors.
Patients were asked to quantify the delay between
pressing the trigger of the PCA pump and the onset
of analgesia. Patients were also asked about the
presence of pain or discomfort at the cannula site and
its relation to pressing the PCA trigger. There was
always an anaesthetist available to deal with any
problems relating to the PCA regimen. PCA was
discontinued when there was a consistent decline in
use and patients were able to take oral analgesics. At
discontinuation of the s.c. PCA, the cannula was
removed and the site inspected.
Pain was scored using a four-point, self-reporting
score, which has been validated previously [14, 16],
as follows: 1 = no pain; 2 = not really sore; 3 =
quite sore; 4 = very sore. Assessments were made
both at rest and during a specified movement (vital
capacity breath followed by a cough). Children were
not wakened from sleep for assessment unless the
nurse suspected oversedation and "A" was recorded
on the chart at these times. Sedation was scored
using a four-point scale as follows: 0 = eyes open
spontaneously; 1 = eyes open to speech; 2 = eyes
open when shaken; 3 = unrousable. Nausea was
scored on a four-point scale: 0 = none; 1 = nausea
only; 2 = vomited once in the past 1 h; 3 = vomited
more than once in the past 1 h.
If a pain score of > 4, or a sedation or nausea score
of 3 was recorded, an anaesthetist was asked to see
the patient.
Results were analysed using the Mann-Whitney
U test for pain scores and morphine consumption
and chi-square tests for comparison of events
between groups.
RESULTS
Patient data are shown in table I. The two groups
were similar in age, weight, gender distribution and
duration of PCA use. Patients in group IV self-
administered significantly more morphine than those
in group SC (P < 0.05). Group SC had a
significantly greater percentage of valid demands
than group IV (P < 0.01).
Pain scores were compared by calculating the
median total pain score during each 4-h period after
operation and comparing the groups during each of
these periods (at rest and during movement). Figure
1 shows the pain scores in the two groups. There
were no significant differences between the groups at
rest or during movement at any of these times.
There were significantly more Spo, recordings of
less than 94 % in group IV than in group SC (P <
0.01) (table II). Sp02 readings were regarded as valid
and recorded only if they persisted over a period of
5 min, if there was a good pulse signal on the
oximeter screen and artefacts caused by poor
positioning or venous engorgement had been ex¬
cluded. The least values recorded were 85 % in
group IV and 87% in group SC.
There were no significant differences in the
incidence of postoperative nausea and vomiting or of
oversedation (sedation score of 2 = eyes open to
shake or 3 = unrousable) in the two groups (table
II). There were no sedation scores of 3 in any
patient.
Twenty-eight patients in group SC were aware of
bolus infusions shortly after making a demand. Five
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Fig. 1. Median (range) 4-hourly pain scores at rest and during movement for the two groups. ■ = Group IV at rest;
H = group SC at rest; □ = group IV during movement; £2 = group SC during movement.
Table II. Incidence of hypoxic episodes (SPq2 recordings of less than
94% ),postoperative nausea andvomiting (PONV ) andoversedation
in groups IV and SC. ** P < 0.01 (chi-square = 8.3)
Group IV Group SC
5po2<94% 193 123**
•Spo.^94% 1202 1090
PONV present 95 65
PONV absent 1300 1148
Sedation score of 2 10 8
Sedation score of 0 or 1 1385 1205
patients in group SC complained of pain at the
cannulation site during bolus infusion. In all of these
five patients, bolus doses stopped being painful after
several hours of PCA use. Four patients in group IV
were able to feel bolus infusions. No patients in this
group complained of pain during bolus infusions.
When asked to comment on the interval between
making a demand and subsequent analgesia, 25
patients in group SC and 15 patients in group IV
described this delay as being less than 5 min.
In group SC, nine patients had a localized
erythematous flare at the cannulation site which
started soon after commencement of PCA. In all
cases this faded after several hours. In group SC, no
problems were observed at the s.c. site after removal
of the cannula.
DISCUSSION
This study has shown that s.c. PCA appeared to be
as effective and safe for acute postoperative pain as
i.v. PCA. It also suggested that the s.c. route may
have advantages over the i.v. route. There was a
lesser consumption of morphine (in patients under¬
going the same procedure) associated with a greater
proportion of valid demands for analgesia. This was
possibly because of the fact that with s.c. PCA, the
patient was aware of bolus infusions and the demand
for analgesia had been successful. Because of this,
patients expected the demand to produce analgesia
and tended not to make further invalid demands
during the lockout period. The usefulness of a
positive feedback to the patient that a demand has
been successful has been noted previously [17, 18]
and PCA pumps which produce different sounds
after valid and invalid demands for analgesia are
being developed. It should be remembered that
group SC received a background infusion of
5 pg kg-1 h"1 (compared with 4 pg kg-1 h_1 in group
IV) and this may have been partly responsible for a
reduced requirement for self-administered morphine
in group SC. This would not, however, explain the
reduction in total morphine consumption in group
SC compared with group IV.
The reduction in hypoxic episodes during s.c.
PCA compared with i.v. PCA may reflect two
possible mechanisms. The reduction in morphine
consumption during s.c. PCA may result in less
ventilatory depression than would otherwise be the
case. Alternatively, differences in the pharmaco¬
kinetics of the two routes of administration may
result in lesser peak concentrations of morphine if
boluses are given s.c. rather than i.v. Limited data
[19] concerning the absorption of morphine during
i.v. and s.c. infusions in adults suggest that both
routes are equally effective but there are no data
concerning absorption after intermittent bolus ad¬
ministration. The fact that there was no difference
between the groups in the incidence of oversedation
suggests that morphine consumption in group IV
was not excessive.
In patients breathing air, pulse oximetry is a
sensitive monitor of ventilation [20], Consideration
of the ideal alveolar gas equation shows that with an
inspired oxygen concentration of 21 %, a small
increase in alveolar carbon dioxide tension produces
a decrease in alveolar oxygen tension and consequent
hypoxaemia. An arterial oxygen saturation of 94 %
corresponds to an arterial oxygen tension of approxi¬
mately 10 kPa and is associated with mild ventilatory
impairment in healthy patients. This is a non¬
specific monitor of ventilation and discrimination
between the possible causes (excess opioid and pain)
requires assessment of opioid consumption and the
level of sedation. A patient who is hypoxic because of
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excess opioid will be sedated while a patient in pain
will be alert and unwilling to take a deep breath and
cough.
Although the s.c. route of administration is very
satisfactory for infusion analgesia in chronic and
terminal pain and also acute pain, there is concern
that absorption of bolus doses is so slow as to make
it unsuitable for use with PCA. This proved not to
be the case and in all patients the delay in receiving
analgesia after a demand was of the order of a few
minutes. We did not attempt to assess this interval
accurately because of difficulties for patients in
judging time accurately during the postoperative
period.
In summary, s.c. PCA appears to be as effective
and safe as i.v. PCA and it may offer advantages over
the i.v. route by providing feedback on successful
demands for analgesia and enhancing appropriate
use of the machine.
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Prevention of postoperative nausea and vomiting with transdermal
hyoscine in children using patient-controlled analgesia
E. Doyle, G. Byers, L. R. McNicol and N. S. Morton
SUMMARY
\Ne have studied 40 children aged 6-14 yr under¬
going abdominal surgery under general anaesthesia
with extradural block; they were allocated randomly
to receive transdermal hyoscine (loading dose
140 gg, followed by 5 pg h1) or placebo for the
duration of postoperative analgesia with PCA
morphine. There was a significant (P <0.001)
reduction in the incidence of postoperative nausea
and vomiting in the treated group compared with
the placebo group during the first 48 h after
operation. The treated group also had a significantly
increased incidence of sedation (P < 0.02) and dry
mouth (P <0.01). (Br. J. Anaesth. 1994; 72:
72-76)
been shown to have a significant antiemetic effect in
motion sickness [14-16]. Transdermal application of
hyoscine offers potential advantages in the pre¬
vention of PONV. It produces steady, small plasma
concentrations of hyoscine [17] and avoids the
problems of a short half-life, brief duration of action
and large peak plasma concentrations which occur
after i.m. injection. In paediatric practice the
avoidance of i.m. injections is a particular advantage
[18].
We have undertaken a prospective, placebo-
controlled, double-blind assessment of the efficacy of
transdermal hyoscine in preventing PONV in chil¬
dren using PCA morphine after abdominal surgery.
KEY WORDS
Analgesia: patient-controlled. paediatric, postoperative.
Analgesics, opioid: morphine. Vomiting: nausea.
Postoperative nausea and vomiting (PONV) occurs
in 40-100 % of patients [1-5]. The causes include the
effects of premedicant drugs, anaesthetic agents,
postoperative analgesics (especially opioids), the
surgery itself and the susceptibility of the patient.
PONV appears to be a significant problem in patients
who use patient-controlled analgesia (PCA) for
postoperative pain relief [6] and, although distressing
for a number of children using this form of
postoperative analgesia, PONV appears to be less of
a problem in children using PCA than it is in adults
[7-10],
Several agents with different modes of action are
used commonly to treat PONV, including pheno-
thiazines, butyrophenones, antihistamines, dop¬
amine antagonists and anticholinergics. Children are
sensitive to the extrapyramidal effects of some of
these drugs [11].
The anticholinergic agent, hyoscine, has been
shown to have an antiemetic effect when given i.m.
[12, 13]. There is also a preparation of hyoscine in
the form of a plaster for transdermal application
(Scopoderm TTS (Ciba)) which contains hyoscine
1.5 mg. This releases hyoscine 140 pg soon after
application, followed by 5 pg h 1 for up to 72 h while
the plaster is in place, giving an average absorption
rate of hyoscine 500 pg in 72 h. The preparation has
PATIENTS AND METHODS
The study was approved by the local Ethics
Committee and informed written consent was
obtained from the parents of children participating
in the study. We studied 40 children aged 6—14 yr
undergoing abdominal surgery. Exclusion criteria
included inability to operate a PCA machine,
unsuitability for extradural anaesthesia and the use
of centrally acting or antiemetic drugs within the
previous 1 week. Based on previous studies showing
the efficacy of this preparation of hyoscine in
reducing PONV, we calculated a 90 % probability of
finding a difference between the groups which would
be significant at the 5 % level. Patients were
instructed before operation in the use of a PCA
machine for postoperative analgesia.
A standard anaesthetic technique was used for all
patients. Premedication comprised diazepam 0.3 mg
kg 1 orally, 2-4 h before operation. Anaesthesia was
induced with propofol 3 mg kg 1 (plus lignocaine
0.2 mg kg"1) and vecuronium 0.1 mg kg V The tra¬
chea was intubated and the lungs ventilated with
67% nitrous oxide in oxygen, with 0.5-2.0%
isoflurane as indicated clinically. The patient was
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then turned to the lateral position and a single
extradural injection of 0.25 % bupivacaine 2 mg kg-1
(maximum 75 mg) given in the lumbar region. At the
end of surgery, residual neuromuscular block was
antagonized with neostigmine and glycopyrronium
in appropriate doses.
Patients were allocated randomly, by means of
computer-generated randomization, to two groups
of 20 patients. Group H (hyoscine) received a
hyoscine patch and group P (placebo) received an
inactive patch. After the induction of anaesthesia and
before the start of surgery, patients in group H had
a hyoscine patch applied to the skin in the left
postauricular area and this was covered with an
Elastoplast dressing. Patients in group P had the
dressing alone applied to the postauricular skin.
Before the patient left the recovery area, the PCA
machine was connected (Graseby PCAS). The
solution used consisted of morphine 1 mg kg 1
diluted in 50 ml of normal saline to give a dilution of
20 pg kg"1 ml"1. The PCA machine was attached to
the side arm of a Cardiff one-way valve incorporated
into the i.v. infusion cannula. The settings used were
a bolus dose of 1 ml (20 pg kg"1), with a lockout
interval of 5 min. There was no background infusion.
If necessary, the patient was given increments of
morphine 50 pg kg"1 in the recovery area.
After operation, the patient breathed air. We used
a monitoring procedure described previously [19];
this involved a high dependency level of nursing care
with hourly recordings of Spo.p ventilatory fre¬
quency, sedation score, pain score and nausea score.
The number of demands made and the volume of
solution infused by the PCA machine were recorded
hourly. PCA was discontinued when the patient was
able to take oral analgesics and there was a consistent
decline in analgesic use.
Pain was scored using a four-point, self-reporting
score which has been validated previously [20]: 0 =
no pain; 1 = not really sore; 2 = quite sore; 3 = very
sore.
Children were not woken from sleep unless the
nurse suspected oversedation; "A" was recorded on
the chart at these times. Sedation was scored using a
four-point scale: 0 = eyes open spontaneously; 1 =
eyes open to speech; 2 = eyes open to shake; 3 =
unrousable.
Nausea and vomiting were scored using a four-
point scale: 0 = no nausea or vomiting; 1 = nausea
only; 2 = vomited once in the past 1 h; 3 = vomited
more than once in the past 1 h.
The patient was questioned on each day after
operation for the presence of dry mouth and blurred
vision. All assessments were made by staff who were
unaware if the patient had received hyoscine or
placebo.
Prochlorperazine was prescribed for use in both
groups if an antiemetic was considered necessary to
treat persistent nausea or vomiting. The hyoscine or
placebo patches were removed at the time of
discontinuation of PCA.
Results were analysed using the unpaired t test for
patient data, the Mann-Whitney U test for pain
scores and morphine consumption and chi-square
tests for comparisons of events between groups.
RESULTS
Patient data and details of surgery and morphine
consumption are shown in table I. Of the
laparotomies performed, six in group H and seven in
group P involved bowel surgery.
There was a significant reduction in the incidence
of PONV in group H compared with group P (P <
0.001) during the period of postoperative use of PCA
(table II) (for the purposes of analysis, PONV was
considered to be present if a nausea score other than
0 was recorded at the hourly recordings). There was
a significant antiemetic effect of hyoscine in patients
aged less than 10 yr and in those aged 10 yr or more.
There was also a significant reduction in the number
of patients who complained of PONV at any time
during the postoperative period in group H (P <
0.05) compared with group P (table II). Six patients
in group P and three in group H vomited on one or
more occasions.
When the antiemetic effect of hyoscine was
analysed for each 24-h period of use there was a
significant (P < 0.01) antiemetic effect during the
first 24 h of use, a significant (P < 0.01) antiemetic
effect in group H compared with group P during the
second 24 h after operation and no significant
antiemetic effect in group H compared with group P
during the third 24 h after operation (table III).
Two patients in group P received one dose each of
prochlorperazine (Stemetil) i.v. during PCA usage.
There were no significant differences between the
groups in pain scores at any time during the
postoperative period.
Table I. Patient data and details of morphine consumption (mean
(SD))
Group H Group P
Sex (M/F) 6/14 7/13
Age (months) 134 (76-169) 122 (86-171)
Weight (kg) 39.5 (13.4) 36.9 (11.9)
Duration of anaesthesia 101 (41) 108 (44)
(min)
Duration of surgery (min) 80 (36.4) 79 (40.4)
Duration of PCA use (h) 50 (9.9) 48 (14.6)
Morphine consumption
(lag kg"1) 1410(734) 1190 (872)





Reimplantation of ureters 3 1
Bladder neck repair 2 0
Laparotomy 6 11
Table II. PONV in groups H and P: incidence during PCA usage
(.assessed by hourly nausea scores) and at any time in the postoperative
period, fFor difference in group H compared with that in group P
Group H Group P yS P
During PCA
Present 29 69
21.3, < O.OOlfAbsent 646 554
Any time after op.
Present 6 14
4.9, < 0.05fAbsent 14 6
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Table III. Incidence of PONV in groups H and P during the first,
second and third 24-h periods after operation. -fFor reduction in
group H compared with that in group P
Group H Group P l\P
First 24 h
Present 20 45
8.9, < O.OlfAbsent 268 264
Second 24 h
Present 8 17
6.9, < O.OlfAbsent 317 225
Third 24 h
Present 1 5
2.7, V O o Ul —hAbsent 65 63
Table IV. Side effects in groups H and P: incidence of oversedation,
Sp0 readings less than 94%, dry mouth during the second and third
days after operation and blurred vision after operation. *Between
groups
Group H Group P x2, P
Sedation score 2 32




No dry mouth 1
Blurred vision 1
No blurred vision 19
The number of occasions on which patients were
considered to be excessively sedated (sedation scores
of 2 = eyes open to shake; 3 = unrousable) was
significantly (P < 0.02) greater for score 2 in group
H (table IV). There were no scores of 3 in either
group.
There was no significant difference between the
groups in the number of occasions on which Sp(hi
less than 94% was recorded (table IV). One patient
in group H was excluded from this analysis because
he was receiving supplementary oxygen as a result of
a pneumothorax produced during a nephrectomy.
There was no significant difference in the in¬
cidence of dry mouth during the first day after
operation, but during the second and third days
there was a significantly greater incidence of this
symptom in group H (P < 0.01) (table IV).
There was no significant difference in the in¬
cidence of blurred vision between groups during the
postoperative period (table IV).
One child in group H suffered hallucinations when
the hyoscine patch had been in place for 36 h. This
responded quickly to removal of the patch and
cleaning of the application site. There were no local
reactions at the site of patch application in any
patient.
DISCUSSION
In this study we have found a significant antiemetic
effect of transdermal hyoscine. Children generally
suffer less from PONV than adults when PCA is
used: the incidence varies from 4% to 34% [7-10]
compared with 38-82% in adults [6,21,22].
Although the majority of nausea scores in our
placebo group were 0, this reflects the frequency of
observation. More than 67 % of patients in group P
suffered from PONV, which is a distressing symp¬
tom in many patients.
The use of propofol as an induction agent,
followed by inhalation agents, causes less PONV
than thiopentone [23-25] and it has been suggested
that propofol has antiemetic effects [26]. Avoidance
of preoperative opioid premedication and intra¬
operative opioids is likely to reduce total opioid
consumption. An extradural block provides analgesia
into the postoperative period and reduces the
requirements for PCA morphine in the early post¬
operative period.
It has been suggested that transdermal hyoscine
should be applied several hours before surgery [27],
so that therapeutic plasma concentrations are
attained perioperatively. It is possible that a more
marked antiemetic effect would have been found if
we had done this rather than apply the patches at
induction of anaesthesia. The time to first tolerating
oral fluids is often regarded as a useful indicator of
the duration and impact of PONV, but it is not a
precise indicator, as it is influenced by individual
ward routines, and for this reason was not adopted in
our study.
Other studies of the efficacy of transdermal
hyoscine in the prevention of PONV are contra¬
dictory. Two studies [21,22] used transdermal
hyoscine in combination with PCA after intra¬
abdominal gynaecological surgery without regional
block. The first [21] found a reduction in PONV
immediately after operation and on the third day
after operation. The treated group required 50% of
the number of supplementary doses of antiemetic as
those in the placebo group. Preoperative opioids
were omitted and fentanyl was given during op¬
eration. The other study [22] found a significant
antiemetic effect of transdermal hyoscine compared
with placebo and a reduced need for supplementary
droperidol in the treated group. There was no opioid
premedication and fentanyl was given during op¬
eration.
Two studies [28, 29] in patients receiving extra¬
dural morphine for postoperative analgesia showed
that transdermal hyoscine had a significantly greater
antiemetic effect than placebo, with a reduced
requirement for supplementary antiemetics. One of
these [28] examined patients undergoing intra¬
abdominal gynaecological surgery with general an¬
aesthesia and intraoperative extradural block and the
other [29] was in women undergoing Caesarean
section with extradural block.
Transdermal hyoscine has also been found to be
effective after orthopaedic and plastic surgery [30].
In contrast, Koski and colleagues [31] found no
effect of transdermal hyoscine on the incidence of
PONV in female patients. However, this study was
not well controlled. Tigerstedt, Salmela and Aromaa
[32] also found transdermal hyoscine was no more
effective than placebo or intraoperative droperidol in
preventing PONV. In this study, a range of surgical
procedures was involved, the hyoscine patch was
applied only 50 min before surgery, an opioid
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operative fentanyl, and postoperative analgesia was
with i.m. opioids.
The finding of an increased incidence of dry
mouth in our patients in group H is in keeping with
the results of several previous studies [22, 29-31,
33], We found no difference between groups H and
P in the incidence of dry mouth on the first day,
probably because of the high incidence of this
symptom in all patients soon after abdominal
surgery, as a result of preoperative fasting and
tracheal intubation.
Other studies have reported visual disturbances
induced by hyoscine used for both travel sickness
[14] and after operation [5, 21, 31-33]. We found no
difference in the incidence of this symptom between
groups H and P. This may be because children are
less affected, or because this symptom is less
troublesome to children.
Psychosis has been reported after transdermal
hyoscine [34,35] in adults and children. It is
unusual, and treated easily by removal of the patch
and cleaning of the skin.
In summary, we have found a useful antiemetic
effect of transdermal hyoscine during the first 48 h
after operation in children undergoing abdominal
surgery with balanced anaesthesia when post¬
operative analgesia was provided by PCA morphine.
Use of the hyoscine patch was associated with an
increase in the incidence of sedation and dry mouth.
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